Abstract
This chapter intends to portray the present knowledge on site and mechanism of action of the ergot alkaloids. The presentation is based chietly on selected work performed in defined isolated systems in which the interference with specific substrates usually called receptors has been sufficiently proven. We hope that this presentation will contribute to the understanding of the complexity of ergot pharmacology as presented in the following chapters.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aberg, G., Andersson, R., Welin-Fogelberg, I.: Inhibition of tone in the taenia of the guinea pig caecum. Europ. J. Pharmacol. 7, 296–299 (1969)
Abrahams, S.L.: Effect of serotonin, LSD, and other indoleamines on adenyl cyclase in the liver fluke. Fed. Proc. 33, 1249 (1974)
Abrahams, S.L., Northup, J.K., Mansour, T.E.: Adenosine cyclic 3′, 5′-monophosphate in the liver fluke, Fasciola hepatica. I. Activation of adenylate cyclase by 5-hydroxyptamine. Molec. Pharmacol. 12, 49–58 (1976)
Acheson, G.H.: The responses of the nictitating membrane of the cat to certain stimulants after ergotoxine. Amer. J. Physiol. 128, 695–702 (1940)
Aellig, W.H.: Periphere Kreislaufwirkungen von Ergotamin, Dihydroergotamin und 1-Methylergotamin an der innervierten, perfundierten Hinterextremitat des Hundes. Helv. physiol. Pharmacol. Acta 25, 374–396 (1967)
Aellig, W.H.: Venoconstrictor effect of dihydroergotamine in superficial hand veins. Europ. J. clin. Pharmacol. 7, 137–139 (1974)
Aellig, W.H., Berde, B.: Studies of the effect of natural and synthetic polypeptide type ergot compounds on a peripheral vascular bed. Brit. J. Pharmacol. 36, 561–570 (1969)
Aghajanian, G.K.: Influence of drugs on the firing of serotonin-containing neurons in brain. Fed. Proc. 31, 91–96 (1972a)
Aghajanian, G.K.: Chemical feedback regulation of serotonin-containing neurons in brain. Ann. N.Y. Acad. Sci. 193, 86–94 (1972b)
Aghajanian, G.K., Haigler, H.J.: Mode of action of LSD on serotonergic neurons. Adv. Biochem. Psychopharmacol. 10, 167–177 (1974)
Aghajanian, G.K., Weiss, B.L.: Block by LSD of the increase in brain serotonin turnover induced by elevated ambient temperature. Nature (Lond.) 220, 795–796 (1968)
Aghajanian, G.K., Rosecrans, J.A., Sheard, M.H.: Serotonin: release in the forebrain by stimulation of midbrain raphe. Science 156, 402–403 (1967)
Aghajanian, G.K., Foote, W.E., Sheard, M.H.: Lysergic acid diethylamide: sensitive neuronal units in the midbrain raphe. Science 161, 706–708 (1968)
Aghajanian, G.K., Foote, W.E., Sheard, M.H.: Action of psychotogenic drugs on single midbrain raphe neurons. J. Pharmacol. exp. Ther. 171, 178–187 (1970a)
Aghajanian, G.K., Graham, A.W., Sheard, M.H.: Serotonin-containing neurons in brain: depression of firing by monoamine oxidase inhibitors. Science 169, 1100–1102 (1970b)
Aghajanian, G.K., Haigler, H.J., Bloom, F.E.: Lysergic acid diethylamide and serotonin: direct actions on serotonin-containing neurons in rat brain. Life Sci. 11(I), 615–622 (1972)
Aghajanian, G.K., Kuhar, M.J., Roth, R.H.: Serotonin-containing neuronal perikarya and terminals: differential effects of p-chlorophenylalanine. Brain Res. 54, 85–101 (1973)
Ahlquist, R.P.: A study of the adrenotropic receptors. Amer. J. Physiol. 153, 586–600 (1948)
Ahlquist, R.P., Levy, B.: Adrenergic receptive mechanism of canine ileum. J. Pharmacol. exp. Ther. 127, 146–149 (1959)
Aiello, E., Guideri, G.: Nervous control of ciliary activity. Science 146, 1692–1693 (1964)
Aiello, E., Guideri, G.: Relationship between 5-hydroxy tryptamine and nerve stimulation of ciliary activity. J. Pharmacol. exp. Ther. 154, 517–523 (1966)
Aiello, E., Paparo, A.: A role for acetylcholine in the regulation of ciliary activity. Comp. gen. Pharmacol. 5, 285–297 (1974)
Alabaster, V.A., Bakhle, Y.S.: Release of smooth muscle-contracting substances from isolated perfused lungs. Europ. J. Pharmacol. 35, 349–360 (1976)
Allen, G.S., Henderson, L.M., Chou, S.N., French, L.A.: Cerebral arterial spasm. Part 2: In vitro contractile activity of serotonin in human serum and CSF on the canine basilar artery, and its blockage by methylsergide and phenoxybenzamine. J. Neurosurg. 40, 442–450 (1974)
Altura, B.M., Malaviya, D., Reich, C.F., Orkin, L.R.: Effects of vasoactive agents on isolated human umbilical arteries and veins. Amer. J. Physiol. 222, 345–355 (1972)
Ambache, N., Zar, M.A.: Evidence against adrenergic motor transmission in the guinea-pig vas deferens. J. Physiol. (Lond.) 216, 359–389 (1971)
Ambache, N., Dunk, L.P., Miall, P., Zar, M.A.: Unexplained inhibitory action of D-lysergic acid diethylamide (LSD) on postganglionic motor transmission in the guinea-pig vas deferens. Brit. J. Pharmacol. 42, 659P–660P (1971)
Ambache, N., Dunk, L.P., Verney, J., Zar, M.A.: An inhibition of post-ganglionic motor transmission in the mammalian vas deferens by D-lysergic acid diethylamide. J. Physiol. (Lond.) 231, 251–270 (1973a)
Ambache, N., Killick, S.W., Srinivasan, V., Zar, M.A.: Presynaptic inhibition of adrenergic motor transmission in rat anococcygeus muscle by D-lysergic acid diethylamide (LSD). J. Physiol. (Lond.) 233, 35P–37P (1973b)
Ambache, N., Killick, S.W., Srinivasan, V., Zar, M.A.: Effects of lysergic acid diethylamide on autonomic postganglionic transmission. J. Physiol. (Lond.) 246, 571–593 (1975)
Ames, A. III, Pollen, D.A.: Neurotransmission in central nervous tissue: A study of isolated rabbit retina. J. Neurophysiol. 32, 424–442 (1969)
Ammon, R.: Die Cholinesterase. Ergebn. Enzymforsch. 4, 102–110 (1935)
Andén, N.-E.: Changes in the impulse flow of central monoamine nerves by drugs affecting monoamine receptors. Acta pharmacol. (Kbh.) 25, 5–6 (1968)
Andén, N.-E., Dahlström, A., Fuxe, K., Larsson, K., Olson, L., Ungerstedt, U.: Ascending monoamine neurons to the telencephalon and diencephalon. Acta physiol. scand. 67, 313–326 (1966)
Andén, N.-E., Corrodi, H., Fuxe, K., Hökfelt, T.: Evidence for a central 5-hydroxytryptamine receptor stimulation by lysergic acid diethylamide. Brit. J. Pharmacol. 34, 1–7 (1968)
Andén, N.-E., Carlsson, A., Haggendal, J.: Adrenergic mechanisms. Annu. Rev. Pharmacol. 9, 119–134 (1969)
Anderson, E.G.: Bulbospinal serotonin-containing neurons and motor control. Fed. Proc. 31, 107–112 (1972)
Anderson, E.G., Baker, R.G., Banna, N.R.: The effects of monoamine oxidase inhibitors on spinal synaptic activity. J. Pharmacol. exp. Ther. 158, 405–415 (1967)
Ansell, G.B., Beeson, M.F., Bradley, P.B.: The effects of stressful stimuli and drugs on the concentrations and turnover rates of monoamines in rat brain. In: The Present Status of Psychotropic Drugs. Cerletti, A., Bové, F.J. (eds.), pp. 299–301. Amsterdam: Exerpta Medica Foundation 1969
Apperley, E., Humphrey, P.P.A., Levy, G.P.: Receptors for 5-hydroxytryptamine and noradrenaline in rabbit aorta and central ear artery. Brit. J. Pharmacol. 52, 131P–132P (1974)
Apperley, E., Humphrey, P.P.A., Levy, G.P.: Receptors for 5-hydroxytryptamine and noradrenaline in rabbit isolated ear artery and aorta. Brit. J. Pharmacol. 58, 211–221 (1976)
Arcari, G., Dorigotti, L., Fregnan, G.B., Glasser, A.H.: Vasodilating and alpha-receptor blocking activity of a new ergoline derivative. Brit. J. Pharmacol. 34, 700P (1968)
Arcari, G., Bernardi, L., Bosisio, G., Coda, S., Fregnan, G.B., Glässer, A.H.: 10-Methoxyergoline derivatives as α-adrenergic blocking agents. Experientia (Basel) 28, 819–820 (1972)
Arefolov, V.A., Pidevich, I.N., Panasyuk, L.V., Firsov, V.K.: Pharmacological analysis of some adrenomimetic effects of serotonin. Byul. eksp. Biol. Med. 80, 45–48 (1975)
Ariens, E.J.: Affinity and intrinsic activity in the theory of competitive inhibition. Part I: Problems and theory. Arch. int. Pharmacodyn. 99, 32–49 (1954)
Ariens, E.J., Van Rossum, J.M., Simonis, A.M.: A theoretical basis of molecular pharmacology. Part II: Interactions of one or two compounds with two interdependent receptor systems. Arzneimittel-Forsch. 6, 611–621 (1956)
Arunlakshana, O., Schild, H.O.: Some quantitative uses of drug antagonists. Brit. J. Pharmacol. 14, 48–58 (1959)
Ascher, P.: Inhibitory and excitatory effects of dopamine on Aplysia neurones. J. Physiol. (Lond.) 225, 173–209 (1972)
Åström, A., Samelius, U.: The action of 5-hydroxytryptamine and some of its antagonists on the umbilical vessels of the human placenta. Brit. J. Pharmacol. 12, 410–414 (1957)
Bach, N.J., Hall, D.A., Kornfeld, E.C.: Descarboxylysergic acid (9,10-didehydro-6-methylergoline). J. med. Chem. 17, 312–314 (1974)
Bacq, Z.M.: The action of ergotamine on the chromatophores of the catfish (Ameiurus nebulosus). Biol. Bull. 65, 387–388 (1933)
Bacq, Z.M.: La pharmacologic du système nerveux autonome, et particulièrement du sympathique, d’après la théorie neurohumorale. Ann. Physiol. 10, 468–528 (1934a)
Bacq, Z.M.: Action de l’ergotamine et de l’ergotaminine sur la membrane nictitante. C.R. Soc. Biol. (Paris) 116, 341–342 (1934b)
Bacq, Z.M.: Recherches sur la physiologie du système nerveux autonome. IV. Réactions de la vésicule séminale et du canal déférent du cobaye à l’adrénaline, à l’acétylcholine et aux ions Ca et K. Arch. int. Pharmacodyn. 47, 123–129 (1934c)
Bakhle, Y.S., Smith, T.W.: Release of spasmogenic substances induced by vasoactive amines from isolated lungs. Brit. J. Pharmacol. 46, 543P–544P (1972)
Bakhle, Y.S., Smith, T.W.: The nature of the tryptamine receptor mediating spasmogen release from rat isolated lungs. Brit. J. Pharmacol. 50, 463P (1974a)
Bakhle, Y.S., Smith, T.W.: Tryptamine receptors in rat pulmonary artery. Brit. J. Pharmacol. 51, 459–461 (1974b)
Baldratti, G., Arcari, G., Suchowsky, G.K.: Studies on a compound antagonistic to 5-hydroxytryptamine. Experientia (Basel) 21, 396–397 (1965)
Banna, N.R., Anderson, E.G.: The effects of 5-hydroxytryptamine antagonists on spinal neuronal activity. J. Pharmacol. exp. Ther. 162, 319–325 (1968)
Barabe, J., Park, W.K., Regoli, D.: Application of drug receptor theories to the analysis of the myotropic effects of bradykinin. Canad. J. Physiol. Pharmacol. 53, 345–353 (1975)
Barasi, S., Roberts, M.H.T.: The action of 5-hydroxytryptamine antagonists and precursors on bulbospinal facilitation of spinal reflexes. Brain Res. 52, 385–388 (1973)
Barasi, S., Roberts, M.H.T.: The modification of lumbar motoneurone excitability by stimulation of a putative 5-hydroxy-tryptamine pathway. Brit. J. Pharmacol. 52, 339–348 (1974)
Barfknecht, C.F., Nichols, D.E., Rusterholz, D.B., Long, J.P., Engelbrecht, J.A., Beaton, J.M., Bradley, R.J., Dyer, D.C.: Potential psychotomimetics. 2-amino-1,2,3,4-tetrahydronaphthalene analogs. J. med. Chem. 16, 804–808 (1973)
Barlow, R.B.: Effects on amine oxydase of substances which antagonize 5-hydroxytryptamine more than tryptamine on the rat fundus strip preparation. Brit. J. Pharmacol. 16, 153–162 (1961)
Barlow, R.B., Khan, I.: Actions of some analogues of tryptamine on the rat uterus and on the isolated rat fundus strip preparation. Brit. J. Pharmacol. 14, 99–107 (1959a)
Barlow, R.B., Khan, I.: Actions of some analogues of 5-hydroxy-tryptamine on the isolated rat uterus and the rat fundus strip preparations. Brit. J. Pharmacol. 14, 265–272 (1959b)
Barthel, W., Markwardt, F.: Aggregation of blood platelets by biogenic amines and its inhibition by antiadrenergic and antiserotoninergic agents. Biochem. Pharmacol. 23, 37–45 (1974)
Barthel, W., Markwardt, F.: Aggregation of blood platelets by adrenaline and its uptake. Biochem. Pharmacol. 24, 1903–1904 (1975)
Bartlet, A.L.: Actions of putative transmitters in the chicken vagus nerve/oesophagus and Remak nerve/rectum preparations. Brit. J. Pharmacol. 51, 549–558 (1974)
Bartlet, A.L., Hassan, T.: Some actions of histamine and 5-hydroxytryptamine on isolated chicken oesophagus. Brit. J. Pharmacol. 32, 156–163 (1968)
Barzaghi, F., Baumgartner, H.R., Carruba, M., Mantegazza, P., Pletscher, A.: The 5-hydroxytryptamine-like actions of 5,6-dihydroxytryptamine. Brit. J. Pharmacol. 48, 245–254 (1973)
Beernink, K.D., Nelson, S.D., Mansour, T.E.: Effect of lysergic acid derivatives on the liver fluke Fasciola hepatica. Int. J. Neuropharmacol. 2, 105–112 (1963)
Belamarich, F.A., Simoneit, L.W.: Aggregation of duck thrombocytes by 5-hydroxytryptamine. Micro vasc. Res. 6, 229–234 (1973)
Beleslin, D., Varagić, V.: The effect of cooling and of 5-hydroxytryptamine on the peristaltic reflex of the isolated guinea-pig ileum. Brit. J. Pharmacol. 13, 266–270 (1958)
Belisle, S., Gagnon, D.J.: Stimulating action of catecholamines on isolated preparations of the rat colon and human and rabbit taeniae coli. Brit. J. Pharmacol. 41, 361–366 (1971)
Bell, J.A., Martin, W.R.: Studies of tryptamine and lysergic acid diethylamide (LSD) on cutaneous C-fiber and polysynaptic reflexes in the cat. J. Pharmacol. exp. Ther. 190, 492–500 (1974)
Benfey, B.G., Cohen, J., Kunos, G, Vermes-Kunos, I.: Dissociation of 5-hydroxytryptamine effects on myocardial contractility and cyclic AMP accumulation. Brit. J. Pharmacol. 50, 581–585 (1974)
Bennett, A., Stockley, H.L.: The intrinsic innervation of the human alimentary tract and its relation to function. Gut 16, 443–453 (1975)
Bennett, J.L., Aghajanian, G.K.: D-LSD binding to brain homogenates: Possible relationship to serotonin receptors. Life Sci. 15, 1935–1944 (1974)
Bennett, J.L., Aghajanian, G.K.: Response of single raphe neurons to (+)-LSD: Correlation with (+)-LSD binding in brain. J. Pharm. Pharmacol. 28, 516–518 (1976)
Bennett, J.L., Bueding, E.: Uptake of 5-hydroxytryptamine by Schistosoma mansoni. Molec. Pharmacol. 9, 311–319 (1973)
Bennett, J.P., Snyder, S.H.: Stereospecific binding of D-lysergic acid diethylamide (LSD) to brain membranes: relationship to serotonin receptors. Brain Res. 94, 523–544 (1975)
Bennett, J.P., Snyder, S.H.: Serotonin and lysergic acid diethylamide binding in rat brain membranes: relationship to postsynaptic serotonin receptors. Molec. Pharmacol. 12, 373–389 (1976)
Bennett, M.R., Middleton, J.: An electrophysiological analysis of the effects of amine-uptake blockers and α-adrenoceptor blockers on adrenergic neuromuscular transmission. Brit. J. Pharmacol. 55, 87–95 (1975)
Berde, B.: New studies on the circulatory effects of ergot compounds with implications to migraine. In: Background to Migraine. Cumings, J.N. (ed.), pp. 66–75. London: William Heinemann Medical Books 1971
Berde, B.: Some new vascular and biochemical aspects of the mechanism of action of ergot compounds. Headache 11, 139–147 (1972)
Berde, B., Cerletti, A.: Über den Melanophoreneffekt von D-Lysergsäure-diäthylamid und verwandten Verbindungen. Helv. physiol. pharmacol. Acta 14, 325–333 (1956)
Berde, B., Cerletti, A.: Über den Angriffspunkt von D-Lysergsäure-diäthylamid und 5-Hydroxytryptamin im Melanophorentest. Z. ges. exp. Med. 129, 149–153 (1957)
Berde, B., Doepfner, W., Cerletti, A.: Über die Wirkungsdauer einiger Serotoninantagonisten. Helv. physiol. pharmacol. Acta 18, 537–544 (1960)
Beretta, C., Locatelli, A.: Inhibitory activity of 8β-carbobenzyloxyaminomethyl-1,6-dimethyl-10α-ergoline towards stimulant effects by 5-hydroxytryptamine and amphetamine on liver fluke, Fasciola hepatica, in vitro. J. Pharm. Pharmacol. 20, 744–748 (1968)
Beretta, C., Ferrini, R., Glässer, A.H.: 1-Methyl-8β-carbobenzyloxy-aminomethyl-10α-ergoline, a potent and long-lasting 5-hydroxytryptamine antagonist. Nature (Lond.) 207, 421–422 (1965a)
Beretta, C., Glässer, A.H., Nobili, M.B., Silvestri, R.: Antagonism of 5-hydroxytryptamine-induced bronchospasm in guinea-pigs by 8β-carbobenzyloxyaminomethyl-1,6-dimethyl-10α-ergoline. J. Pharm. Pharmacol. 17, 423–428 (1965b)
Bernardi, L., Bosisio, G., Elli, C., Patelli, B., Temperilli, A., Arcari, G., Glässer, H.A.: Ergoline derivatives. Note XIII. α-adrenergic blocking drugs. Farmaco [Sci.] 30, 789–801 (1975)
Berridge, M.J., Prince, W.T.: Mode of action of hallucinogenic molecules. Nature (Lond.) New Biol. 243, 283–284 (1973)
Berridge, M.J., Prince, W.T.: The nature of the binding between LSD and a 5-HT receptor: A possible explanation for hallucinogenic activity. Brit. J. Pharmacol. 51, 269–278 (1974)
Berry, P.A., Collier, H.O.J.: Bronchoconstrictor action and antagonism of a slow-reacting substance from anaphylaxis of guinea-pig isolated lung. Brit. J. Pharmacol. 23, 201–216 (1964)
Berry, M.S., Cottrell, G.A.: Excitatory, inhibitory and biphasic synaptic potentials mediated by an identified dopamine-containing neurone. J. Physiol. (Lond.) 244, 589–612 (1975)
Bevan, P., Bradshaw, C.M., Roberts, M.H.T., Szabadi, E.: The effect of microelectrophoretically applied mescaline on cortical neurones. Neuropharmacology 13, 1033–1045 (1974a)
Bevan, P., Bradshaw, C.M., Szabadi, E.: Potentiation and antagonism of neuronal responses to monoamines by methysergide and sotalol. Brit. J. Pharmacol. 50, 445 P (1974b)
Bhattacharya, B.K.: A pharmacological study on the effect of 5-hydroxytryptamine and its antagonists on the bronchial musculature. Arch. int. Pharmacodyn. 103, 357–367 (1955)
Biber, B., Fara, J., Lundgren, O.: A pharmacological study of intestinal vasodilator mechanisms in the cat. Acta physiol. scand. 90, 673–683 (1974)
Bickerton, R.K., Rockhold, W.T., Micalizzi, E.R.: Use of isolated strips of cat spleen for the assay of a-adrenergic blocking compounds. J. Pharm. Sci. 51, 837–840 (1962)
Bindler, E.H., Gyermek, L.: Influence of 5-HT antagonists on the ganglionic stimulant action of 5-HT and DMPP. Fed. Proc. 20, 319 (1961)
Bircher, R., Schalch, W.R.: Über die Wirkung von Mutterkornalkaloiden bei histaminergischen Reaktionen. Helv. physiol. pharmacol. Acta 6, 813–820 (1948)
Birmingham, A.T., Szolcsányi, J.: Competitive blockade of adrenergic α-receptors and histamine receptors by thymoxamine. J. Pharm. Pharmacol. 17, 449–458 (1965)
Birmingham, A.T., Wilson, A.B.: Preganglionic and postganglionic stimulation of the guineapig isolated vas deferens preparation. Brit. J. Pharmacol. 21, 569–580 (1963)
Birnbaumer, L., Pohl, S.L., Kaumann, A.J.: Receptors and acceptors: A necessary distinction in hormone binding studies. Adv. Cyclic Nucleotide Res. 4, 239–281 (1974)
Blakeley, A.G.H., Brown, G.L., Ferry, C.B.: Pharmacological experiments on the release of the sympathetic transmitter. J. Physiol. (Lond.) 167, 505–514 (1963)
Bloom, F.E., Costa, E., Salmoiraghi, G.C.: Analysis of individual rabbit olfactory bulb neuron responses to the microelectrophoresis of acetylcholine, norepinephrine and serotonin synergists and antagonists. J. Pharmacol. exp. Ther. 146, 16–23 (1964)
Bloom, F.E., Hoffer, B.J., Siggins, G.R., Barker, J.L., Nicoll, R.A.: Effects of serotonin on central neurons: Microiontophoretic administration. Fed. Proc. 31, 97–106 (1972)
Bloom, F.E., Hoffer, B.J., Nelson, C., Sheu, Y., Siggins, G.R.: The physiology and pharmacology of serotonin mediated synapses. In: Serotonin and Behavior. Barchas, J., Usdin, E. (eds.), pp. 249–261. New York: Academic Press 1973
Boakes, R.J., Bradley, P.B., Briggs, I., Dray, A.: Antagonism by LSD to effects of 5-HT on single neurones. Brain Res. 15, 529–531 (1969)
Boakes, R.J., Bradley, P.B., Briggs, I., Dray, A.: Effects of lysergic acid derivatives on 5-hydroxytryptamine excitation of brain stem neurones. Brit. J. Pharmacol. 38, 453P–454P (1970a)
Boakes, R.J., Bradley, P.B., Briggs, I., Dray, A.: Antagonism of 5-hydroxytryptamine by LSD-25 in the central nervous system: A possible neuronal basis for the actions of LSD-25. Brit. J. Pharmacol. 40, 202–218 (1970b)
Boggan, W.O., Freedman, D.X.: LSD tolerance and brain serotonin metabolism. Fed. Proc. 32, 694 (1973)
Bond, H.W., Guth, P.S.: Interaction of 5-hydroxytryptamine and lysergic acid diethylamide in the central nervous system. Pharmacologist 6, 171 (1964)
Born, G.V.R.: The uptake of adrenaline by human blood platelets. Naunyn-Schmiedebergs Arch. Pharmacol. 259, 155–156 (1967)
Born, G.V.R., Smith, J.B.: Uptake, metabolism and release of [3H]-adrenaline by human platelets. Brit. J. Pharmacol. 39, 765–778 (1970)
Born, G.V.R., Mills, D.C.B., Roberts, G.C.K.: Potentiation of platelet aggregation by adrenaline. J. Physiol. (Lond.) 191, 43P–44P (1967a)
Born, G.V.R., Day, M., Stockbridge, A.: The uptake of amines by human erythrocytes in vitro. J. Physiol. (Lond.) 193, 405–418 (1967b)
Born, G.V.R., Juengjaroen, K., Michal, F.: Relative activities on and uptake by human blood platelets of 5-hydroxytryptamine and several analogues. Brit. J. Pharmacol. 44, 117–139 (1972)
Borsy, J., Magó-Karacsony, E., Balogh, T., Pik, K.: Preparation new semi-synthetic lysergic acid derivatives: Investigation into the correlation of molecular structure and antiserotonin activity II. Acta pharm. hung. 43, 207–217 (1973)
Boullin, D.J., Green, A.R.: Effect of brain 5-HT agonists and antagonists on platelet aggregation. Sixth Internat. Congr. Pharmacol., Helsinki, 1975. Abstract 695
Boullin, D.J., Green, A.R., Grimes, R.P.J.: Human blood platelet aggregation induced by dopamine, 5-hydroxytryptamine and analogues. J. Physiol. (Lond.) 252, 46P–47P (1975a)
Boullin, D.J., Grimes, R.P.J., Orr, M.W.: The actions of flupethixol upon 5-hydroxytryptamine-induced aggregation and the uptake of 5-hydroxytryptamine and dopamine by human blood platelets. Brit. J. Pharmacol. 55, 555–557 (1975b)
Boyd, H., Chang, V., Rand, M.J.: The anticholinesterase activity of some antiadrenaline agents. Brit. J. Pharmacol. 15, 525–531 (1960)
Bradley, P.B.: The effects of 5-hydroxytryptamine on the electrical activity of the brain and on behaviour in the conscious cat. In: 5-Hydroxytryptamine. Lewis, G.P. (ed.), pp. 214–220. London: Pergamon Press 1958
Bradley, P.B., Hance, A.J.: The effects of intraventricular injections of D-lysergic acid diethylamide (LSD 25) and 5-hydroxytryptamine (serotonin) on the electrical activity of the brain of the conscious cat. J. Physiol. (Lond.) 132, 50P–51P (1956a)
Bradley, P.B., Hance, A.J.: The effects of intraventricular injections of drugs on the electrical activity of the brain of the conscious cat. Electroenceph. clin. Neurophysiol. 8, 699–700 (1956b)
Bradley, P.B., Wolstencroft, J.H.: The action of drugs on single neurones in the brain stem. In: Neuro-Psychopharmacology. Bradley, P.B., Fluegel, F., Hoch, P.H. (eds.), pp. 237–240. Amsterdam: Elsevier 1964
Bradley, P.B., Wolstencroft, J.H.: Actions of drugs on single neurones in the brain stem. Brit. med. Bull. 21, 15–18 (1965)
Bradshaw, C.M., Roberts, M.H.T., Szabadi, E.: Effect of mescaline on single cortical neurones. Brit. J. Pharmacol. 43, 871–873 (1971)
Bramwell, G.J., Gonye, T.: Responses of midbrain neurones to iontophoretically applied 5-hydroxytryptamine. Brit. J. Pharmacol. 48, 357P–358P (1973)
Briggs, I.: Excitatory responses to raphe stimulation in the rat bulbar reticular formation. J. Physiol. (Lond.) 256, 111P (1976)
Brodie, B.B.: Storage and release of 5-hydroxytryptamine (HT). Possible significance in chemical mediation in brain. In: Ciba Symposium on Hypertension, pp. 64–83. London: Churchill 1954
Brodie, B., Shore, P.A., Pletscher, A.: Serotonin-releasing activity limited to Rauwolfia alkaloids with tranquilizing action. Science 123, 992–993 (1956)
Broom, W.A., Clark, A.J.: The standardisation of ergot preparations. J. Pharmacol. exp. Ther. 22, 59–74 (1923)
Brown, B.E.: Proctolin: A peptide transmitter candidate in insects. Life Sci. 17, 1241–1252 (1975)
Brown, L.: The release and fate of the transmitter liberated by adrenergic nerves. Proc. roy. Soc. B 162, 1–19 (1965)
Brown, G.L., Dale, H.: The pharmacology of ergometrine. Proc. roy. Soc. B 118, 446–477 (1935)
Brown, G.L., Gillespie, J.S.: The output of sympathetic transmitter from the spleen of the cat. J. Physiol. (Lond.) 138, 81–102 (1957)
Brown, G.L., Davies, B.N., Ferry, C.B.: The effect of neuronal rest on the output of sympathetic transmitter from the spleen. J. Physiol. (Lond.) 159, 365–380 (1961)
Brownlee, G., Johnson, E.S.: The site of the 5-hydroxytryptamine receptor on the intramural nervous plexus of the guinea-pig isolated ileum. Brit. J. Pharmacol. 21, 306–322 (1963)
Brügger, I.: Experimenteller Beitrag zur Wirkungsweise vegetativer Pharmaka. Arch. int. Pharmacodyn. 59, 43–60 (1938)
Brügger, J.: Die isolierte Samenblase des Meerschweinchens als biologisches Testobjekt zur quantitativen Differenzierung der sympathikolytischen Wirkung der genuinen Mutterkornalkaloide und ihrer Dihydroderivate. Helv. physiol. pharmacol. Acta 3, 117–134 (1945)
Brundin, J.: The effect of prostaglandin E on the response of the rabbit oviduct to hypogastric nerve stimulation. Acta physiol. scand.73, 54–57 (1968)
Buchan, P., Lewis, A.J., Sugrue, M.F.: A comparison of the accumulation of noradrenaline and 5-hydroxytryptamine into arterial smooth muscle. Brit. J. Pharmacol. 52, 132P–133P (1974)
Bucknell, A., Whitney, B.: A preliminary investigation of the pharmacology of the human isolated taenia coli preparation. Brit. J. Pharmacol. 23, 164–175 (1964)
Bullard, B.: The nervous control of the anterior byssus retractor muscle of Mytilus edulis. Comp. Biochem. Physiol. 23, 749–759 (1967)
Burgers, A.C.J., Imai, K.: The melanophore-stimulating potency of single pituitary glands of normal and of D-lysergic acid diethylamide (D-LSD)-treated Xenopus laevis. Gen. comp. Endocr. 2, 603–604 (1962)
Burgers, A.C.J., Leemreis, W., Dominiczak, T., Van Oordt, G.J.: Inhibition of the secretion of intermedine by D-lysergic acid diethylamide (LSD-25) in the toad, Xenopus laevis. Acta endocr. (Kbh.) 29, 191–200 (1958)
Burgers, A.C.J., Zandee, D.I., Van Bakel, J.M.M., Hillemans, G.M.L., Van Oordt, G.J.: The effect of LSD-derivatives and serotonin on the melanophores of the toad, Xenopus laevis. Acta physiol. pharmacol. need. 11, 341–342 (1962)
Burn, J.H., Ng, K.K.F.: The action of Hydergine at postganglionic sympathetic terminations. J. Physiol. (Lond.) 175, 66P (1964)
Burnstein, S., Levin, E., Varanelli, C.: Prostaglandins and cannabis — II. Inhibition of biosynthesis by the naturally occurring cannabinoids. Biochem. Pharmacol. 22, 2908–2910 (1973)
Burt, D.R., Creese, I., Snyder, S.H.: Binding interaction of lysergic acid diethylamide and related agents with dopamine receptors in the brain. Molec. Pharmacol. 12, 631–638 (1976a)
Burt, D.R., Creese, I., Snyder, S.H.: Properties of [3H] haloperidol and [3H]dopamine binding associated with dopamine receptors in calf brain membranes. Molec. Pharmacol. 12, 800–812 (1976b)
Cambridge, G.W., Holgate, J.A.: Superfusion as a method for the study of drug antagonism. Brit. J. Pharmacol. 10, 326–334 (1955)
Cannon, W.B., Rosenblueth, A.: Autonomic neuro-effector systems. Experimental Biology Monographs. New York: MacMillan 1937
Carlsson, A., Lindqvist, M: The effect of L-tryptophan and some psychotropic drugs on the formation of 5-hydroxytryptophan in the mouse brain in vivo. J. Neural Transm. 33, 23–43 (1972)
Carlsson, A., Shore, P.A., Brodie, B.B.: Release of serotonin from blood platelets by reserpine in vitro. J. Pharmacol. exp. Ther. 120, 334–339 (1957)
Carlsson, A., Bedard, P., Lindqvist, M., Magnusson, T.: The influence of nerve-impulse flow on the synthesis and metabolism of 5-hydroxytryptamine. Biochem. J. 128, 70P–71P (1972a)
Carlsson, A., Bedard, P., Lindqvist, M., Magnusson, T.: The influence of nerve-impulse flow on the synthesis and metabolism of 5-hydroxytryptamine in the central nervous system. In: Neurotransmitters and Metabolic Regulation. Smellie, R.M.S. (ed.), pp. 17–32. London: The Biochemical Society 1972b
Carpi, A., Virno, M.: The action of ergotamine on the intracranial venous pressure and on the cerebral venous outflow of the dog. Brit. J. Pharmacol. 12, 232–239 (1957)
Carroll, P.R., Glover, W.E.: Independence of the vasoconstrictor and the potentiating effects of 5-hydroxytryptamine and some ergot derivatives. Proc. Aust. physiol. pharmacol. Soc. 4, 40 (1973)
Carroll, P.R., Ebeling, P.W., Glover, W.E.: Vascular responses to some drugs used in the treatment of migraine. Abstracts, Australasian Society for Clinical and Experimental Pharmacologists, November 1972
Carroll, P.R., Ebeling, P.W., Glover, W.E.: The responses of the human temporal and rabbit ear artery to 5-hydroxytryptamine and some of its antagonists. Ajebak 52, 813–823 (1974)
Casentini, S., Galli, G.: Serotonina, antiserotoninici e motilita gastrica. Boll. Soc. ital. Biol. sper. 32, 1640–1642 (1956)
Cerletti, A.: Lysergic acid diethylamide (LSD) and related compounds. In: Neuropharmacology. Abramson, H.A. (ed.), pp. 9–84. Trans. Second Conf. Princeton: Josiah Macy, Jr., Foundation 1955
Cerletti, A.: Ergostin — Neue Perspektiven der Chemie und Pharmakologie des Mutterkorns. Med. exp. (Basel) 8, 278–286 (1963)
Cerletti, A., Berde, B.: Die Wirkung von D-Lysergsäure-diäthylamid (LSD 25) und 5-Oxytryptamin auf die Chromatophoren von Poecilia reticulatus. Experientia (Basel) 11, 312–313 (1955)
Cerletti, A., Berde, B.: New approaches in the development of compounds from ergot with potential therapeutic use in migraine. In: Background to Migraine. Smith, R. (ed.), pp. 53–64. London: William Heinemann Medical Books 1967
Cerletti, A., Doepfner, W.: Über die 5-Oxytryptamin-hemmende Wirkung von LSD-Derivaten und andern Lysergsäureamiden am isolierten Rattenuterus. 20th Intern. Physiol. Congress Bruxelles, 1956, Abstr. Comm., pp. 165–166
Cerletti, A., Doepfner, W.: Spezifische Steigerung der serotonin-antagonistischen Wirkung von Lysergsäurederivaten durch Methylierung des Indolstickstoffes der Lysergsäure. Helv. physiol. pharmacol. Acta 16, C55–C57 (1958a)
Cerletti, A., Doepfner, W.: Comparative study on the serotonin antagonism of amide derivatives of lysergic acid and of ergot alkaloids. J. Pharmacol. exp. Ther. 122, 124–136 (1958b)
Cerletti, A., Konzett, H.: Spezifische Hemmung von 5-Oxytryptamin-Effekten durch Lysergsäurediäthylamid und ähnliche Körper. Naunyn-Schmiedebergs Arch. Pharmacol. 228, 146–148 (1956)
Cerletti, A., Rothlin, E.: Role of 5-hydroxytryptamine in mental diseases and its antagonism to lysergic acid derivatives. Nature (Lond.) 176, 785–786 (1955)
Chahl, L.A., Ladd, R.J.: The effects of prostaglandins E1, E2 and F2α on the cutaneous vasculature of the rat. Brit. J. Pharmacol. 56, 317–322 (1976)
Chahl, L.A., O’Donnell, S.R.: The effects on some receptors of guinea-pig trachea of a series of sympathomimetic amines. Europ. J. Pharmacol. 16, 201–208 (1971)
Chambers, P.N., Marshall, P.B.: Similar pharmacological properties of ergometrine and methysergide. J. Pharm. Pharmacol. 19, 65 (1967)
Chan, P.S., Ellenbogen, L.: New evidence for the β-adrenergic receptor blocking activity of dihydroergotamine. Arch. int. Pharmacodyn. 209, 204–213 (1974)
Chase, T.N., Breese, G.R., Kopin, I.J.: Serotonin release from brain slices by electrical stimulation: Regional differences and effect of LSD. Science 157, 1461–1463 (1967)
Chase, T.N., Katz, R.I., Kopin, I.J.: Release of [3H] serotonin from brain slices. J. Neurochem. 16, 607–615 (1969)
Chodera, A.: Blockade of 5-hydroxytryptamine antidiuresis in rats by 2-bromlysergic acid diethylamide tartrate and 1-methyl-lysergic acid butanolamide. J. Pharm. Pharmacol. 15, 386–389 (1963)
Chong, G.C., Phillis, J.W.: Pharmacological studies on the heart of Tapes watlingi: A mollusc of the family Veneridae. Brit. J. Pharmacol. 25, 481–496 (1965)
Christ, D.D., Nishi, S.: Site of adrenaline blockade in the superior cervical ganglion of the rabbit. J. Physiol. (Lond.) 213, 107–117 (1971)
Christian, S.T., McClain, L.D., Morin, R.D., Benington, F.: Blockage of LSD binding at its high affinity site on synaptosomal membranes by 1-methyl-1,2,5,6-tetrahydropyridine-N,N-diethyl-carboxamide. Experientia (Basel) 31, 910–911 (1975)
Chu, D., Sturmer, E.: Studies on the mechanism of action of dihydroergotamine (DHE) on the vascular bed of cat skeletal muscle. Brit. J. Pharmacol. 48, 331P–332P (1973)
Chu, D., Owen, D.A.A., Stürmer, E.: Effects of ergotamine and dihydroergotamine on the resistance and capacitance vessels of skin and skeletal muscle in the cat. Postgrad. med. J. 52 (Suppl. 1), 32–36 (1976)
Church, M.K.: Response of rat lung to humoral mediators of anaphylaxis and its modification by drugs and sensitization. Brit. J. Pharmacol. 55, 423–430 (1975)
Church, M.K., Miller, P.: Simple models of anaphylaxis and of histamine and 5-hydroxytryptamine induced inflammation using the mouse pinna. Brit. J. Pharmacol. 55, 315P (1975)
Cima, G., Freschi, C.: Attivitá della serotonina e dei suoi antagonisti sull’uretere isolato. Boll. Soc. ital. Biol. sper. 33, 867–869 (1957)
Cleugh, J., Gaddum, J.H., Holton, P., Leach, E.: Assay of substance P on the fowl rectal caecum. Brit. J. Pharmacol. 17, 144–158 (1961)
Clineschmidt, B.V., Anderson, E.G.: Lysergic acid diethylamide: antagonism of supraspinal inhibiton of spinal reflexes. Brain Res. 16, 296–300 (1969)
Clineschmidt, B.V., Anderson, E.G.: The blockade of bulbospinal inhibition by 5-hydroxytryptamine antagonists. Exp. Brain Res. 11, 175–186 (1970)
Clineschmidt, B.V., Lotti, V.J.: Indoleamine antagonists: relative potencies as inhibitors of tryptamine-and 5-hydroxytryptophan-evoked responses. Brit. J. Pharmacol. 50, 311–313 (1974)
Closse, A., Hauser, D.: Dihydroergotamine binding to rat brain membranes. Life Sci. 19, 1851–1864 (1976)
Cohen, M.L., Berkowitz, B.A.: Differences between the effects of dopamine and apomorphine on rat aortic strips. Europ. J. Pharmacol. 34, 49–58 (1975)
Collier, J.G., Nachev, C., Robinson, B.F.: Effect of catecholamines and other vasoactive substances on superficial hand veins in man. Clin. Sci. 43, 455–467 (1972)
Constantine, J.W., Knott, C.: Benzquinamide and the 5-hydroxytryptamine receptors in guinea pig trachea. J. Pharmacol. exp. Ther. 146, 400–403 (1964)
Cools, A.R.: Two topographically, functionally and pharmacologically distinct dopamine-sensitive sites within the cat brain. Sixth Internat. Congr. Pharmacol., Helsinki, 1975, Abstract 1149
Cools, A.R., Van Rossum, J.M.: Excitation-mediating and inhibition-mediating dopaminereceptors: A new concept towards a better understanding of electrophysiological, biochemical, pharmacological, functional and clinical data. Psychopharmacologia 45, 243–254 (1976)
Cools, A.R., Struyker Boudier, H.A.J., Van Rossum, J.M.: Depamine receptors: Selective agonists and antagonists of functionally distinct types within the feline brain. Europ. J. Pharmacol. 37, 283–293 (1976)
Corrodi, H., Fuxe, K., Hökfelt, T., Lidbrink, P., Ungerstedt, U.: Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons. J. Pharm. Pharmacol. 25, 409–412 (1973)
Corrodi, H., Farnebo, L.O., Fuxe, K., Hamberger, B.: Effect of ergot drugs on central 5-hydroxytryptamine neurons: evidence for 5-hydroxytryptamine release or 5-hydroxytryptamine receptor stimulation. Europ. J. Pharmacol. 30, 172–181 (1975)
Costa, E.: Effects of hallucinogenic and tranquilizing drugs on serotonin evoked uterine contractions. Proc. Soc. exp. Biol. (N.Y.) 91, 39–41 (1956)
Costa, E., Zetler, G.: Interactions between epinephrine and some psychotomimetic drugs. J. Pharmacol. exp. Ther. 125, 230–236 (1959)
Costall, B., Naylor, R.J.: Apomorphine as an antagonist of the dopamine response from the nucleus accumbens. J. Pharm. Pharmacol. 28, 592–595 (1976)
Cottrell, G.A.: Direct post-synaptic responses to stimulation of serotonin-containing neurons. Nature (Lond.) 225, 1060–1062 (1970a)
Cottrell, G.A.: Actions of LSD-25 and reserpine on a serotonergic synapse. J. Physiol. (Lond.) 208, 28P–29P (1970b)
Cottrell, G.A., Macon, J.B.: Synaptic connexions of two symmetrically placed giant serotonin-containing neurones. J. Physiol. (Lond.) 236, 435–464 (1974)
Cottrell, G.A., Berry, M.S., Macon, J.B.: Synapses of a giant serotonin neurone and a giant dopamine neurone: studies using antagonists. Neuropharmacology 13, 431–439 (1974)
Couch, J.R.: Blockade of excitatory 5-HT synapse by LSD. Pharmacologist 16, 244 (1974)
Creese, I., Burt, D.R., Snyder, S.H.: The dopamine receptor: differential binding of D-LSD and related agents to agonist and antagonist states. Life Sci. 17, 1715–1720 (1976)
Cripps, H., Dearnaley, D.P.: Evidence suggesting uptake of noradrenaline at adrenergic receptors in the isolated blood-perfused cat spleen. J. Physiol. (Lond.) 216, 55P–56P (1971)
Cripps, H., Dearnaley, D.P.: Vascular responses and noradrenaline overflow in the isolated blood-perfused cat spleen: some effects of cocaine, normetanephrine and α-blocking agents. J. Physiol. (Lond.) 227, 647–664 (1972)
Crossman, A.R., ElKhawad, A.O.A., Walker, R.J., Woodruff, G.N.: Effects of ergometrine on dopamine receptors. J. Physiol. (Lond.) 232, 59P (1973)
Crunkhorn, P., Meacock, S.C.R.: Mediators of the inflammation induced in the rat paw by carrageenin. Brit. J. Pharmacol. 42, 392–402 (1971)
Crunkhorn, P., Willis, A.L.: Cutaneous reactions to intradermal prostaglandins. Brit. J. Pharmacol. 41, 49–56 (1971)
Cuatrecasas, P., Greaves, M.F.: Receptors and recognition. Series A, Vol. I. London: Chapman and Hall; New York: Wiley 1976
Cuatrecasas, P., Hollenberg, M.D., Chang, K.-J., Bennett, V.: Hormone receptor complexes and their modulation of membrane function. Recent Progr. Hormone Res. 31, 37–94 (1975)
Cumings, J.N.: The relationship of serotonin and platelets in migraine. Arch. Neurobiol. 37 (Suppl.), 67–75, 77–84 (1974)
Cumings, J.N., Hilton, B.P.: Effects of methysergide on platelets incubated with reserpine. Brit. J. Pharmacol. 42, 611–619 (1971)
Curtis, D.R., Davis, R.: A central action of 5-hydroxytryptamine and noradrenaline. Nature (Lond.) 192, 1083–1084 (1961)
Curtis, D.R., Davis, R.: Pharmacological studies upon neurons of the lateral geniculate nucleus of the cat. Brit. J. Pharmacol. 18, 217–246 (1962)
Curzon, G., Marsden, C.A.: Effect of LSD on rat brain 5-hydroxytryptamine metabolism at elevated environmental temperature. Brit. J. Pharmacol. 56, 368P–369P (1976)
Dahlström, A., Fuxe, K.: Evidence for the existence of mono-amine neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta physiol. scand. 62 (Suppl. 232), 5–55 (1964)
Dahlström, A., Fuxe, K.: Evidence for the existence of mono-amine neurons in the central nervous system. II. Experimentally induced changes in the intraneuronal amine levels of bulbospinal neuron systems. Acta physiol. scand. 64 (Suppl. 247), 7–36 (1965)
Daicoff, G.R., Chavez, F.R., Anton, A.H., Swenson, E.W.: Serotonin-induced pulmonary venous hypertension in pulmonary embolism. Thorac. cardiovasc. Surg. 56, 810–815 (1968)
Dale, H.H.: On some physiological actions of ergot. J. Physiol. (Lond.) 34, 163–206 (1906)
Dalessio, D.J., Camp, W.A., Goodell, H., Chapman, L.F., Zileli, T., Ramos, A.O., Ehrlich, R., Fortuin, F., McCattell, K., Wolff, H.C.: Studies on headache: the relevance of the prophylactic action of UML-491 in vascular headache of the migraine type to the pathophysiology of this syndrome. Wld Neurol. 3, 66–72 (1962)
Da Graca-Fernandez, M., Osswald, W.: Einfluss von Ergotamin und Pentobarbital auf die Blutdruck-und Nickhautwirkungen von Noradrenalin und Tyramin. Med. Pharmacol. exp. 17, 65–71 (1967)
D’Amico, D.J., Patel, B.C., Klawans, H.L.: The effect of methysergide on 5-hydroxytryptamine turnover in whole brain. J. Pharm. Pharmacol. 28, 454–456 (1976)
Da Prada, M., Saner, A., Burkhard, W.P., Bartholini, G., Pletscher, A.: Evidence for stimulation of cerebral dopamine receptors by LSD. Sixth Internat. Congr. Pharmacol., Helsinki, 1975a, Abstract 187
Da Prada, M., Saner, A., Burkard, W.P., Bartholini, G., Pletscher, A.: Lysergic acid diethylamide: evidence for stimulation of cerebral dopamine receptors. Brain Res. 94, 67–73 (1975b)
Davis, M.E., Adair, F.L., Chen, K.K., Swanson, E.E.: The pharmacologic action of ergotocin, a new ergot principle. J. Pharmacol. exp. Ther. 54, 398–407 (1935)
Davis, W.G: A dual action of 5-hydroxytryptamine on the ovarian suspensory ligament of the rat. J. Pharm. Pharmacol. 28, 502–504 (1976)
Day, M., Vane, J.R.: An analysis of the direct and indirect actions of drugs on the isolated guinea-pig ileum. Brit. J. Pharmacol. 20, 150–170 (1963)
Deffenu, G., Mantegazzini, P.: Effects of 5-hydroxytryptamine on spinal reflexes of the cat. Psychopharmacologia 10, 96–102 (1966)
De La Lande, I.S., Cannel, V.A., Waterson, J.G: The interaction of serotonin and noradrenaline on the perfused artery. Brit. J. Pharmacol. 28, 255–272 (1966)
De La Lande, I.S., Rand, M.J.: A simple isolated nerve-blood vessel preparation. Aust. J. exp. Biol. med. Sci. 43, 639–656 (1965)
Delay, J., Thuillier, J.: Dualité d’action du diethylamide de l’acide lysergique sur la contraction uterine provoquée par la 5-hydroxytryptamine (sérotonine). C.R. Soc. Biol. (Paris) 150, 1335–1336 (1956)
Del Bianco, P.L., Fanciullacci, M., Franchi, G., Sicuteri, F.: Human 5-hydroxytryptamine venomotor receptors. Pharmacol. Res. Commun. 7, 395–408 (1975)
Del Bianco, P.L., Franchi, G., Fanciullacci, M., Sicuteri, F.: Clinical pharmacology of 5-hydroxytryptamine and catecholamines venomotor receptors. Arch. int. Pharmacodyn. 196 (Suppl.), 113–116 (1972)
Del Greco, F., Masson, G.M.C., Corcoran, A.C.: Renal and arterial effects of serotonin in the anesthetized rat. Amer. J. Physiol. 187, 509–514 (1956)
Dengler, H.J., Spiegel, H.E., Titus, E.O.: Effects of drugs on uptake of isotopic norepinephrine by cat tissues. Nature (Lond.) 191, 816–817 (1961)
Dette, G.A., Wesemann, W.: Studies on serotonin binding proteins of nerve ending membranes. J. Neural Transm. 37, 281–295 (1975)
Diab, I.M., Freedman, D.X., Roth, L.J.: [3H] Lysergic acid diethylamide: cellular autoradiographic localization in rat brain. Science 173, 1022–1024 (1971)
Diaz, J.-L., Huttunen, M.O.: Persistent increase in brain serotonin turnover after chronic administration of LSD in the rat. Science 174, 62–64 (1971)
Diaz, P., Ngai, S.H., Costa, E.: The effect of LSD on the metabolism of rat brain serotonin (5-HT). Pharmacologist 9, 251 (1967)
Diaz, P.M., Ngai, S.H., Costa, E.: Factors modulating brain serotonin turnover. Adv. Pharmacol. Chemother. 6B, 75–92 (1968)
Dingledine, R., Goldstein, A., Kendig, J.: Effects of narcotic opiates and serotonin on the electrical behaviour of neurons in the guinea-pig myenteric plexus. Life Sci. 14, 2299–2309 (1974)
Doepfner, W., Cerletti, A.: Über den Serotonin-Antagonismus einiger Antihistaminika unter Berücksichtigung ihrer chemischen Struktur. Int. Arch. Allergy 10, 348–354 (1957)
Doepfner, W., Cerletti, A.: Comparison of lysergic acid derivatives and antihistamines as inhibitors of the edema provoked in the rat’s paw by serotonin. Int. Arch. Allergy 12, 89–97 (1958)
Dougan, D.F.H., McLean, J.R.: Evidence for the presence of dopaminergic nerves and receptors in the intestine of a mollusc, Tapes watlingi. Comp. gen. Pharmacol. 1, 33–46 (1970)
Drakontides, A.B., Gershon, M.D.: 5-Hydroxytryptamine receptors in the mouse duodenum. Brit. J. Pharmacol. 33, 480–492 (1968)
Dretchen, K., Ghoneim, M.M., Long, J.P.: Interactions of serotonin with neuromuscular blocking agents. Europ. J. Pharmacol. 18, 121–127 (1972)
Drew, G.M.: Effects of α-adrenoceptor agonists and antagonists on pre-and postsynaptically located α-adrenoceptors. Europ. J. Pharmacol. 36, 313–320 (1976)
Drummond, A.H., Gordon, J.L.: Platelet release reaction induced by 5-hydroxytryptamine. J. Physiol. (Lond.) 240, 39P–40P (1974)
Drummond, A.H., Gordon, J.L.: Inhibition of 5-hydroxy-[3H]-tryptamine binding to rat blood platelets by 5-HT antagonists and uptake inhibitors. Brit. J. Pharmacol. 55, 257–258 (1975a)
Drummond, A.H., Gordon, J.L.: Specific binding sites for 5-hydroxytryptamine on rat blood platelets. Biochem. J. 150, 129–132 (1975b)
Drummond, A.H., Whigham, K.A.E., Prentice, C.R.M.: Effects of chlorprothixene isomers on platelet 5-hydroxytryptamine receptors: evidence for different 5-hydroxytryptamine conformations at uptake and stimulatory sites. Europ. J. Pharmacol. 37, 385–388 (1976)
Dyer, D.C.: The pharmacology of spirally-cut sheep umbilical blood vessels. Pharmacologist 11, 230 (1969)
Dyer, D.C.: The pharmacology of isolated sheep umbilical blood vessels. J. Pharmacol. exp. Ther. 175, 565–570 (1970)
Dyer, D.C.: Evidence for the action of D-lysergic acid diethylamide, mescaline and bufotenine on 5-hydroxytryptamine receptors in umbilical vasculature. J. Pharmacol. exp. Ther. 188, 336–341 (1974)
Dyer, D.C., Gant, D.W.: Vasoconstriction produced by hallucinogens on isolated human and sheep umbilical vasculature. J. Pharmacol. exp. Ther. 184, 366–375 (1973)
Dyer, D.C., Ueland, K., Eng, M.: Responses of isolated monkey umbilical veins to biogenic amines and polypeptides. Arch. int. Pharmacodyn. 200, 213–221 (1972)
Dykstra, S.L., Berdahl, J.M., Campbell, K.N., Combs, C.M., Lankin, D.G: Phenylindenes and phenylindans with antireserpine activity. J. med. Chem. 10, 418–428 (1967)
Dykstra, S.J., Minielli, J.L., Lawson, J.E., Ferguson, H.C., Dungan, K.W.: Lysergic acid and quinidine analogs. 2-(O-acylamino-phenethyl) piperidines. J. med. Chem. 16, 1015–1020 (1973)
Ehrenpreis, S., Fleisch, J.H., Mittag, T.W.: Approaches to the molecular nature of pharmacological receptors. Pharmacol. Rev. 21, 131–181 (1969)
Eliasson, R., Åström, A.: Pharmacological studies on the perfused human placenta. Acta Pharmacol. (Kbh.) 11, 254–264 (1955)
ElKhawad, A.O., Woodruff, G.N.: Evidence for direct stimulation of dopamine receptors by ergometrine in mice and rats. Sixth Internat. Congr. Pharmacol., Helsinki, 1975, Abstract 1147
ElKhawad, A.O., Munday, K.A., Poat, J.A., Woodruff, G.N.: The effect of dopamine receptor stimulants on locomotor activity and cyclic AMP levels in the rat striatum. Brit. J. Pharmacol. 53, 456P–457P (1975)
Engberg, I., Lundberg, A., Ryall, R.W.: The effect of reserpine on transmission from the flexor reflex afferents. Acta physiol. scand. 68 (Suppl. 277), 45 (1966)
Engberg, I., Lundberg, A., Ryall, R.W.: The effect of reserpine on transmission in the spinal cord. Acta physiol. scand. 72, 115–122 (1968a)
Engberg, I., Lundberg, A., Ryall, R.W.: Is the tonic decerebrate inhibition of reflex paths mediated by monoaminergic pathways? Acta physiol. scand. 72, 123–133 (1968b)
Engelhardt, G.: Zur Pharmakologie des 9,10-Dihydro-10-(1-methyl-4-piperidyliden)-9-anthrol (WA 335), eines Histamin-und Serotoninantagonisten. Arzneimittel-Forsch. 25, 1723–1737 (1975)
Erspamer, V.: Modificazioni delle azioni dell enteramina ad opera di farmaci simpaticomimetici e di farmaci simpaticolitici. Ricerca Sci. 22, 1568–1577 (1952)
Erspamer, V.: Pharmacological studies on enteramine (5-Hydroxytryptamine). Arch. int. Pharmacodyn. 93, 293–316 (1953)
Euler, U.S.v.: Effect of some metabolic factors and drugs on uptake and release of catecholamines in vitro and in vivo. In: New Aspects of Storage and Release Mechanisms of Catecholamines. Schumann, H.J., Kroneberg, G. (eds.), pp. 144–158. Berlin-Heidelberg-New York: Springer 1970
Euler, U.S.v.: Adrenergic nerve particles in relation to uptake and release of neurotransmitter. J. Endocr. 55, 2–9 (1972)
Euler, U.S.v., Hedqvist, P.: Inhibitory action of prostaglandins E1 and E2 on the neuromuscular transmission in the guinea-pig vas deferens. Acta physiol. scand. 77, 510–512 (1969)
Euler, U.S.v., Lishajko, F.: Inhibitory action of adrenergic blocking agents on catecholamine release and uptake in isolated nerve granules. Acta physiol. scand. 68, 257–262 (1966)
Euler, U.S.v., Lishajko, F.: Inhibitory action of adrenergic blocking agents on reuptake and net uptake of noradrenaline in nerve granules. Acta physiol. scand. 74, 501–506 (1968)
Evans, D.H.L., Schild, H.O., Thesleff, S.: Effects of drugs on depolarized plain muscle. J. Physiol. (Lond.) 143, 474–485 (1958)
Eyre, P.: Pharmacology of bovine pulmonary vein anaphylaxis in vitro. Brit. J. Pharmacol. 43, 302–311 (1971)
Eyre, P.: Atypical tryptamine receptors in sheep pulmonary vein. Brit. J. Pharmacol. 55, 329–333 (1975)
Fanchamps, A., Doepfner, W., Weidmann, H., Cerletti, A.: Pharmakologische Charakterisierung von Deseril, einem Serotonin-Antagonisten. Schweiz. med. Wschr. 90, 1040–1046 (1960)
Fanciullacci, M., Franchi, G., Sicuteri, F.: Facilitazione dell’ azione venocostrittrice della 5-idrossitriptamina da ergotamina, metisergide e LSD-25 nell’uomo. Boll. Soc. ital. Biol. sper. 51, 517–522 (1975)
Fara, J.: Mesenteric vasodilator responses to 5-hydroxytryptamine. Gastroenterology 66, 689 (1974)
Farnebo, L.-O., Hamberger, B.: Drug-induced changes in the release of [3H]-noradrenaline from field stimulated rat iris. Brit. J. Pharmacol. 43, 97–106 (1971a)
Farnebo, L.-O., Hamberger, B.: Drug-induced changes in the release of 3H-monoamines from field stimulated rat brain slices. Acta physiol. scand. (Suppl.) 371, 35–44 (1971b)
Farnebo, L.-O., Hamberger, B.: Regulation of [3H] 5-hydroxytryptamine release from rat brain slices. J. Pharm. Pharmacol. 26, 642–644 (1974)
Farrow, J.T., Van Vunakis, H.: Binding of D-lysergic acid diethylamide to subcellular fractions from rat brain. Nature (Lond.) 237, 164–165 (1972)
Farrow, J.T., Van Vunakis, H.: Characteristics of D-lysergic acid diethylamide binding to subcellular fractions derived from rat brain. Biochem. Pharmacol. 22, 1103–1113 (1973)
Feldman, J.M., Lebovitz, H.E.: Specificity of serotonin inhibition of insulin release from golden hamster pancreas. Diabetes 19, 475–479 (1970a)
Feldman, J.M., Lebovitz, H.E.: Mechanism of epinephrine and serotonin inhibition of insulin release in the golden hamster in vitro. Diabetes 19, 480–486 (1970b)
Ferrini, R., Glässer, A.: Antagonism of central effects of tryptamine and 5-hydroxytryptophan by 1,6-dimethyl-8β-carbo-benzyloxyaminomethyl-10α-ergoline). Psychopharmacologia 8, 271–276 (1965)
Fillion, G., Fillion, M.-P., Spirakis, Ch., Bahers, J.-M., Jacob, J.: 5-Hydroxytryptamine binding to synaptic membranes from rat brain. Life Sci. 18, 65–74 (1976)
Fingerman, M., Rao, K.R.: Action of biogenic amines on crustacean chromatophores. Comp. gen. Pharmacol. 1, 341–348 (1970)
Fingl, E., Gaddum, J.H.: Hydroxytryptamine blockade by dihydroergotamine in vitro. Fed. Proc. 12, 320 (1953)
Fishlock, D.J.: The action of 5-hydroxytryptamine on the circular muscle of the human ileum and colon in vitro. J. Physiol. (Lond.) 170, 11P–12P (1964)
Fishlock, D.J., Parks, A.G., Dewell, J.V.: Action of 5-hydroxytryptamine on the human stomach, duodenum and jejunum in vitro. Gut 6, 338–342 (1965)
Fleckenstein, A.: A quantitative study of antagonists of adrenaline on the vessels of the rabbit’s ear. Brit. J. Pharmacol. 7, 553–562 (1952)
Fleisch, J.H., Maling, H.M., Brodie, B.B.: Evidence for existence of alpha-adrenergic receptors in the mammalian trachea. Amer. J. Physiol. 218, 596–599 (1970)
Flückiger, E., Balthasar, H.U.: Dihydroergocristin: Unterschiedliche Wirkungen an venösem und arteriellem Gewebe. Arzneimittel-Forsch. 17, 6–9 (1967)
Flückiger, E., Salzmann, R.: Serotoninantagonismus an der Placenta. Experientia (Basel) 17, 131 (1961)
Foote, W.E., Sheard, M.H., Aghajanian, G.K.: Comparison of effects of LSD and amphetamine on midbrain raphe units. Nature (Lond.) 222, 567–569 (1969)
Fozard, J.R.: Clonidine and methysergide: effects on an isolated artery. Naunyn-Schmiedebergs Arch. Pharmacol. 279 (Suppl.), R21 (1973a)
Fozard, J.R.: Drug interactions on an isolated artery. In: Background to Migraine. Cumings, J.N. (ed.), pp. 150–169. London: William Heinemann Medical Books 1973b
Fozard, J.R.: The mechanisms by which migraine prophylactic drugs modify vascular reactivity in vitro. “Headache ‘76”, Joint Meeting of the Italian Headache and the Scandinavian Migraine Societies, Florence, 1976a, Abstract, pp. 7–8
Fozard, J.R.: Comparative effects of four migraine prophylactic drugs on an isolated extracranial artery. Europ. J. Pharmacol. 36, 127–139 (1976b)
Fozard, J.R., Berry, J.L.: Interactions between antimigraine drugs and a high affinity uptake and storage machanism for 5-hydroxytryptamine. Pharmacology 14, 357–361 (1976)
Fozard, J.R., Leach, G.D.H.: The hypotensive action of 5-hydroxytryptamine (5-HT) in anaesthetised and pithed rats. Europ. J. Pharmacol. 2, 239–249 (1968)
Fozard, J.R., Wright, J.L.: Interaction between antimigraine drugs and a high affinity uptake and storage mechanism for 5-hydroxytryptamine. Sixth Migraine Symposium, London, 1974, Abstract, pp. 9–10
Frankhuijzen, A.L.: Analysis of ergotamine-5-HT interaction on the isolated rat stomach preparation. Europ. J. Pharmacol. 30, 205–212 (1975)
Frankhuijzen, A.L., Bonta, I.L.: Effect of mianserin, a potent anti-serotonin agent, on the isolated rat stomach fundus preparation. Europ. J. Pharmacol. 25, 40–50 (1974a)
Frankhuijzen, A.L., Bonta, I.L.: Receptors involved in the action of 5-HT and tryptamine on the isolated rat stomach fundus preparation. Europ. J. Pharmacol. 26, 220–230 (1974b)
Fredholm, B.B., Rosell, S.: Fate of 3H-noradrenaline in canine subcutaneous adipose tissue. Acta physiol. scand. 80, 404–411 (1970)
Freedman, D.X.: LSD-25 and brain serotonin in reserpinized rat. Fed. Proc. 19, 266 (1960)
Freedman, D.X.: Effects of LSD-25 on brain serotonin. J. Pharmacol. exp. Ther. 134, 160–166 (1961)
Freedman, D.X.: Psychotomimetic drugs and brain biogenic amines. Amer. J. Psychiat. 119, 843–850 (1963)
Freedman, D.X.: Aspects of the biochemical pharmacology of psychotropic drugs. In: Psychiatric Drugs. Solomon, P. (ed.), pp. 32–57. New York: Grune and Stratton 1966
Freedman, D.X.: LSD, psychotogenic procedures and brain neuro-humors. Psychopharmacol. Bull. 11, 42–43 (1975)
Freedman, D.X., Aghajanian, G.K.: Approaches to the pharmacology of LSD-25. Lloydia 29, 309–314 (1967)
Freedman, D.X., Boggan, W.O.: Brain serotonin metabolism after tolerance dosage of LSD. Adv. Biochem. Psychopharmacol. 10, 151–157 (1974)
Freedman, D.X., Coquet, C.A.: Regional and subcellular distribution of LSD and effects on 5-HT levels. Pharmacologist 7, 183 (1965)
Freedman, D.X., Giarman, N.J.: LSD-25 and the status and level of brain serotonin. Ann. N.Y. Acad. Sci. 96, 98–106 (1962)
Freedman, D.X., Gottlieb, R., Lovell, R.A.: Psychotomimetic drugs and brain 5-hydroxytryptamine metabolism. Biochem. Pharmacol. 19, 1181–1188 (1970)
Fregnan, G.B., Glässer, A.H.: Activity of eledoisin, other polypeptides and ergometrine on the uterus in situ of rabbit and other animal species. J. Pharm. Pharmacol. 16, 744–750 (1964)
Fregnan, G.B., Glasser, A.H.: Structure-activity relationship of various acyl derivatives of 6-methyl-8β-aminomethyl-10α-ergoline (dihydrolysergamine). Experientia (Basel) 24, 150–151 (1968)
Froment, J.L., Eskazan, E., Jouvet, M.: Effets du LSD et du méthysergide sur les pointes ponto géniculo occipitales. C.R. Soc. Biol. (Paris) 165, 2153–2157 (1971)
Furchgott, R.F.: Dibenamine blockade in strips of rabbit aorta and its use in differentiating receptors. J. Pharmacol. exp. Ther. 111, 265–284 (1954)
Furchgott, R.F.: The pharmacology of vascular smooth muscle. Pharmacol. Rev. 7, 183–265 (1955)
Furchgott, R.F.: Receptors for sympathomimetic amines. In: Ciba Foundation Symposium on Adrenergic Mechanisms. Wolstenholme, G.E.W., O’Connor, M. (eds.), pp. 246–252. London: J. and A. Churchill 1960
Furchgott, R.F.: The pharmacological differentiation of adrenergic receptors. Ann. N.Y. Acad. Sci. 139, 553–570 (1967)
Furchgott, R.F.: The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In: Handbook of Experimental Pharmacology. Catecholamines. Blaschko, H., Muscholl, E. (eds.), Vol. XXXIII, pp. 283–335. Berlin-Heidelberg-New York: Springer 1972
Furukawa, K., Nomoto, T.: 5-Hydroxytryptamine receptors in isolated rat ileum. Jap. J. Pharmacol. 24 (Suppl.), 95 (1974)
Furukawa, K., Nomoto, T.: Changes in the response to ACh, nicotine and 5-hydroxytryptamine in chemical sympathectomized rat ileum. Jap. J. Pharmacol. 25 (Suppl.), 29P (1975)
Fuxe, K.: Evidence for the existence of monoamine neurons in the central nervous system. IV. Distribution of monoamine terminals in the central nervous system. Acta physiol. scand. 64 (Suppl. 247), 37–85 (1965)
Fuxe, K., Corrodi, H., Hökfelt, T., Lidbrink, P., Ungerstedt, U.: Ergocornine and 2-Br-α-ergocryptine. Evidence for prolonged dopamine receptor stimulation. Med. Biol. 52, 121–132 (1974)
Fuxe, K., Agnati, L., Everitt, B.: Effects of methergoline on central monoamine neurones. Evidence for a selective blockade of central 5-HT receptors. Neurosci. Lett. 1, 283–290 (1975a)
Fuxe, K., Agnati, L.F., Hökfelt, T., Jonsson, G., Lidbrink, P., Ljungdahl, A., Lofstrom, A., Ungerstedt, U.: The effect of dopamine receptor stimulating and blocking agents on the activity of supersensitive dopamine receptors and on the amine turnover in various dopamine nerve terminal systems in the rat brain. J. Pharmacol. (Paris) 6, 117–129 (1975b)
Gaddum, J.H.: The action of adrenalin and ergotamine on the uterus of the rabbit. J. Physiol. (Lond.) 61, 141–150 (1926)
Gaddum, J.H.: Antagonism between lysergic acid diethylamide and 5-hydroxytryptamine. J. Physiol. (Lond.) 121, 15P (1953)
Gaddum, J.H.: Drugs antagonistic to 5-hydroxytryptamine. In: Ciba Symposium on Hypertension. Wolstenholme, G.E.W., Cameron, M.P. (eds.), pp. 75–77. London: J. and A. Churchill 1954
Gaddum, J.H.: Drugs which antagonize the actions of 5-hydroxytryptamine on peripheral tissues. In: 5-Hydroxytryptamine. Lewis, G.P. (ed.), pp. 195–205. New York: Pergamon Press 1957
Gaddum, J.H., Hameed, K.A.: Drugs which antagonize 5-hydroxytryptamine. Brit. J. Pharmacol. 9, 240–248 (1954)
Gaddum, J.H., Paasonen, M.K.: The use of some molluscan hearts for the estimation of 5-hydroxytryptamine. Brit. J. Pharmacol. 10, 474–483 (1955)
Gaddum, J.H., Picarelli, Z.P.: Two kinds of tryptamine receptor. Brit. J. Pharmacol. 12, 323–328 (1957)
Gaddum, J.H., Szerb, J.C.: Assay of substance P on goldfish intestine in a microbath. Brit. J. Pharmacol. 17, 451–463 (1961)
Gaddum, J.H., Vogt, M.: Some central actions of 5-hydroxytryptamine and various antagonists. Brit. J. Pharmacol. 11, 175–179 (1956)
Gaddum, J.H., Hebb, C.O., Silver, A., Swan, A.A.B.: 5-Hydroxytryptamine. Pharmacological action and destruction in perfused lungs. Quart. J. exp. Physiol. 38, 255–262 (1953)
Gaddum, J.H., Hameed, K.A., Hathway, D.E., Stephens, F.F.: Quantitative studies of antagonists for 5-hydroxytryptamine. Quart. J. exp. Physiol. 40, 49–74 (1955)
Gagnon, D.J.: Contraction of the rat colon by sympathomimetic amines: effect of methysergide and 5-HT desensitization. Europ. J. Pharmacol. 17, 319–324 (1972)
Gallager, D.W., Aghajanian, G.K.: Chlorimipramine and LSD: differential effects on the in vivo release of 3H-5HT. Pharmacologist 16, 244 (1974)
Gallager, D.W., Aghajanian, G.K.: Effects of chlorimipramine and lysergic acid diethylamide on efflux of precursor-formed 3H-serotonin: correlations with serotonergic impulse flow. J. Pharmacol. exp. Ther. 193, 785–795 (1975)
Gallager, D.W., Aghajanian, G.K.: Inhibition of firing of raphe neurones by tryptophan and 5-hydroxytryptophan: blockade by inhibiting serotonin synthesis with Ro-4-4602. Neuropharmacology 15, 149–156 (1976)
Gant, D.W., Dyer, D.C.: D-Lysergic acid diethylamide (LSD-25): a constrictor of human umbilical vein. Life Sci. 10, 235–240 (1971)
Garrett, R.L., Brown, J.H.: Bradykinin-potentiated contractions induced by serotonin (5-HT), norepinephrine (NE) and potassium (K+) in rabbit aortic strips. Pharmacologist 12, 263 (1970)
Garrett, R.L., Brown, J.H.: Bradykinin interaction with 5-hydroxytryptamine, norepinephrine and potassium chloride in rabbit aorta. Proc. Soc. exp. Biol. (N.Y.) 139, 1344–1348 (1972)
Garrett, W.J.: The effects of adrenaline, noradrenaline and dihydroergotamine on excised human myometrium. Brit. J. Pharmacol. 10, 39–44 (1955)
Gautrelet, J., Scheiner, H.: Détermination du pouvoir anticholinesterasique de différentes substances par la méthode de la décontraction du muscle droit de l’abdomen de la grenouille contracté par l’acétylcholine. C.R. Soc. Biol. (Paris) 131, 738–740 (1939)
Gelfand, M.D., West, G.B.: Experimental studies with the butanolamide and propanolamide of 1-methyl-lysergic acid. Int. Arch. Allergy 18, 286–291 (1961)
Gerschenfeld, H.M.: Serotonin: Two different inhibitory actions on snail neurons. Science 171, 1252–1254 (1971)
Gerschenfeld, H.M., Paupardin, D.: Actions of 5-hydroxytryptamine on mulluscan neuronal membranes. In: Drug Receptors. Rang, H.P. (ed.), pp. 45–61. London: Macmillan 1972
Gerschenfeld, H.M., Paupardin-Tritsch, D.: Ionic mechanisms and receptor properties underlying the responses of molluscan neurones to 5-hydroxytryptamine. J. Physiol. (Lond.) 243, 427–456 (1974a)
Gerschenfeld, H.M., Paupardin-Tritsch, D.: On the transmitter function of 5-hydroxytryptamine at excitatory and inhibitory monosynaptic junctions. J. Physiol. (Lond.) 243, 457–481 (1974b)
Gerschenfeld, H.M., Paupardin-Tritsch, D.: Excitatory and inhibitory monosynaptic actions mediated by a serotonin ccntaining neuron in Aplysia californica. J. Physiol. (Lond.) 243, 28P–29P (1974c)
Gerschenfeld, H.M., Stefani, E.: 5-Hydroxytryptamine receptors and synaptic transmission in molluscan neurones. Nature (Lond.) 205, 1216–1218 (1965)
Gerschenfeld, H.M., Stefani, E.: An electrophysiological study of 5-hydroxytryptamine receptors of neurones in the molluscan nervous system. J. Physiol. (Lond.) 185, 684–700 (1966)
Gerschenfeld, H.M., Stefani, E.: Acetylcholine and 5-hydroxytryptamine receptors in neurones of the land-snail Cryptomphallus aspersa. J. Physiol. (Lond.) 191, 14P–15P (1967)
Gerschenfeld, H.M., Stefani, E.: Evidence for an excitatory transmitter role of serotonin in molluscan central synapses. In: Advances in Pharmacology. Garattini, S., Shore, P.A. (eds.), pp. 369–392. New York-London: Academic Press 1968
Gerschenfeld, H.M., Tauc, L.: Différents aspects de la pharmacologic des synapses dans le système nerveux central des mollusques. J. Physiol. (Paris) 56, 360–361 (1964)
Gilbert, J.-C., Goldberg, L.I.: Characterization by cyproheptadine of the dopamine-induced contraction in canine isolated arteries. J. Pharmacol. exp. Ther. 193, 435–442 (1975)
Gillespie, J.S., Kirpekar, S.M.: Uptake and release of H3-noradrenaline by the splenic nerves. J. Physiol. (Lond.) 178, 44P–45P (1965a)
Gillespie, J.S., Kirpekar, S.M.: The inactivation of infused noradrenaline by the cat spleen. J. Physiol. (Lond.) 176, 205–227 (1965b)
Gillespie, J.S., McGrath, J.C.: The effect of lysergic acid diethylamide (LSD) on the vas deferens and anococcygeus muscle. Brit. J. Pharmacol. 52, 128P (1974)
Gillespie, J.S., McGrath, J.C: The effects of lysergic acid diethylamide on the response to field stimulation of the rat vas deferens and the rat and cat anococcygeus muscles. Brit. J. Pharmacol. 54, 481–488 (1975)
Gillespie, J.S., Muir, T.C.: A method of stimulating the complete sympathetic outflow from the spinal cord to blood vessels in the pithed rat. Brit. J. Pharmacol. 30, 78–87 (1967)
Gillespie, J.S., Hamilton, D.N.H., Hosie, R.J.A.: The extraneuronal uptake and localization of noradrenaline in the cat spleen and the effect on this of some drugs, of cold and of denervation. J. Physiol. (Lond.) 206, 563–590 (1970)
Ginzel, K.H.: The action of lysergic acid diethylamide (LSD 25), its 2-brom derivative (BOL 148) and of 5-hydroxytryptamine (5-HT) on the peristaltic reflex of the guinea-pig ileum. J. Physiol. (Lond.) 137, 62P–63P (1957)
Ginzel, K.H., Kottegoda, S.R.: A study of the vascular actions of 5-hydroxytryptamine, tryptamine, adrenaline and nor-adrenaline. Quart. J. exp. Physiol. 38, 225–231 (1953)
Glegg, A.M., Turner, P.: Cholinergic interactions of methysergide and cinanserin on isolated human smooth muscle. Arch. int. Pharmacodyn. 191, 301–309 (1971)
Glover, W.E., Marshall, R.J., Whelan, R.F.: The antagonism of the vascular effects of 5-hydroxytryptamine by BOL 148 and sodium salicylate in the human subject. Brit. J. Pharmacol. 12, 498–503 (1957)
Glowinski, J., Hamon, M., Hery, F.: Regulation of 5-HT synthesis in central serotoninergic neurons. In: New Concepts in Neurotransmitter Regulation. Mandell, A.J. (ed.), pp. 239–257. New York: Plenum Press 1973
Görlitz, B.D., Frey, H.H.: Comparison of the blocking effects of antagonists of adrenaline and 5-hydroxytryptamine on their mutual receptors. J. Pharm. Pharmacol. 25, 651–653 (1973)
Goetz, C.G., Klawans, H.L.: Myoclonus, methysergide, and serotonin. Lancet 1974/I, 1284–1285
Gogerty, J.H., Dille, J.M.: Pharmacology of D-lysergic acid morpholide (LSM). J. Pharmacol. exp. Ther. 120, 340–348 (1957)
Gokhale, S.D., Gulati, O.D., Kelkar, L.V., Kelkar, V.V.: Effect of some drugs on human umbilical artery in vitro. Brit. J. Pharmacol. 27, 332–346 (1966)
Goldberg, L.I.: Comparison of putative dopamine receptors in blood vessels and the central nervous system. Adv. Neurol. 9, 53–56 (1975)
Goldberg, L.I., Toda, N.: Dopamine induced relaxation of isolated canine renal, mesenteric and femoral arteries contracted with prostaglandin F2α. Circulat. Res. 36 (Suppl. I), 97–102 (1975)
Goldberg, L.I., Tjandramaga, T.B., Anton, A.H., Toda, N.: New investigations of the cardiovascular actions of dopamine. In: Frontiers in Catecholamine Research. Usdin, E., Snyder, S. (eds.), pp. 513–521. New York: Pergamon Press 1973
Goldman, J.M., Hadley, M.E.: In vitro demonstration of adrenergic receptors controlling melanophore responses of the lizard, Anolis carolinensis. J. Pharmacol. exp. Ther. 166, 1–7 (1969)
Goldman, J.M., Hadley, M.E.: Direct agonistic and antagonistic effects of ergotamine on vertebrate melanophores. Arch. int. Pharmacodyn. 183, 239–246 (1970a)
Goldman, J.M., Hadley, M.E.: Cyclic AMP and adrenergic receptors in melanophore responses to methylxanthines. Europ. J. Pharmacol. 12, 365–370 (1970b)
Goldman, J.M., Hadley, M.E.: Sulfhydryl requirement for alpha adrenergic receptor activity and melanophore stimulating hormone (MSH) action on melanophores. J. Pharmacol. exp. Ther. 182, 93–100 (1972)
Gonzáles, R., Garcia, M., Rojas, R.: The mode of action of serotonin on the isolated atrium of hamsters. Sixth Internat. Congr. Pharmacol., Helsinki, 1975, Abstract 1433
Gordon, J.L., Drummond, A.H.: Irreversible aggregation of pig platelets and release of intracellular constituents induced by 5-hydroxytryptamine. Biochem. Pharmacol. 24, 33–36 (1975)
Greeff, K., Holtz, P.: Über die Uteruswirkung des Adrenalins und Arterenols. Ein Beitrag zum Problem der Uterusinnervation Arch. int. Pharmacodyn. 88, 228–252 (1951)
Greeff, K., Benfey, B.G., Bokelmann, A.: Anaphylaktische Reaktionen am isolierten Herzvorhofpräparat des Meerschweinchens und ihre Beeinflussung durch Antihistaminica, BOL, Dihydroergotamin und Reserpin. Naunyn-Schmiedebergs Arch. Pharmacol. 236, 421–434 (1959)
Greenberg, D.A., U’Prichard, D.C., Snyder, S.H.: Alpha-noradrenergic receptor binding in mammalian brain: differential labeling of agonist and antagonist states. Life Sci. 19, 69–76 (1976)
Greenberg, M.J.: The responses of the venus heart to catecholamines and high concentrations of 5-hydroxytryptamine. Brit. J. Pharmacol. 15, 365–374 (1960a)
Greenberg, M.J.: Structure-activity relationship of tryptamine analogues on the heart of Venus mercenaria. Brit. J. Pharmacol. 15, 375–388 (1960b)
Grove, D.J., O’Neill, J.G., Spillett, P.B.: The action of 5-hydroxytryptamine on longitudinal gastric smooth muscle of the plaice, Pleuronectes platessa. Comp. gen. Pharmacol. 5, 229–238 (1974)
Guimarães, S.: Reversal by pronethalol of dibenamine blockade: A study on the seminal vesicle of the guinea-pig. Brit. J. Pharmacol. 36, 594–601 (1969a)
Guimarães, S.: Alpha excitatory, alpha inhibitory and beta inhibitory adrenergic receptors in the guinea-pig stomach. Arch. int. Pharmacodyn. 179, 188–201 (1969b)
Guimarães, S., Osswald, W.: Adrenergic receptors in the veins of the dog. Europ. J. Pharmacol. 5, 133–140 (1969)
Gulati, O.D., Kelkar, V.V.: Effect of tyramine on human umbilical artery in vitro. Brit. J. Pharmacol. 42, 155–158 (1971)
Guth, P.S., Spirtes, M.A.: Interaction in the central nervous system between serotonin and lysergic acid derivatives. In: Neuropsychopharmacology. Proc. 1st. Intern. Congr. Neuropharmacol., Rome, Bradley, P.B., Deniker, P., Radouco-Thomas, C. (eds.), pp. 319–323. London: Elsevier 1958
Gyermek, L.: The action of 5-hydroxytryptamine on the urinary bladder of the dog. Pharmacologist 2, 89 (1960)
Gyermek, L.: Action of 5-hydroxytryptamine on the urinary bladder of the dog. Arch. int. Pharmacodyn. 137, 137–144 (1962)
Gyermek, L.: Drugs which antagonize 5-hydroxytryptamine and related indolealkylamines. In: 5-Hydroxytryptamine and Related Indolealkylamines. Handbook of Experimental Pharmacology. Eichler, O., Farah, A. (eds.), Vol. XIX, pp. 471–528. Berlin-Heidelberg-New York: Springer 1966
Gyermek, L., Bindler, E.: Blockade of the ganglionic stimulant action of 5-hydroxytryptamine. J. Pharmacol. exp. Ther. 135, 344–348 (1962)
Gyermek, L., Sumi, T.: Potentiating actions of indolealkylamines and lysergic acid diethylamide on reflexes elicited by 5-hydroxytryptamine. Proc. Soc. exp. Biol. (N.Y.) 114, 436–439 (1963)
Gyires, K., Knoll, J.: Inflammation and writhing syndrome inducing effect of PGE1, PGE2 and the inhibition of these actions. Pol. J. Pharmacol. Pharm. 27, 257–264 (1975)
György, L., Borbely, L., Kelemen, B., Somkúti, T.: Über die adrenerg-erregenden Eigenschaften des Ergotoxins. Acta physiol. Acad. Sci. hung. 14, 391–398 (1958a)
György, L., Somkuti, T., Kelemen, B., Borbély, L.: The problem of ergotoxin-adrenaline synergism and antagonism: the effect of general anaesthesia. Acta physiol. Acad. Sci. hung. 14, 287–300 (1958b)
Haefely, W.: Effects of serotonin (5-HT) and some related indole compounds in a mammalian sympathetic ganglion. Experientia (Basel) 27, 1112 (1971)
Haefely, W.: The effects of 5-hydroxytryptamine and some related compounds on the cat superior cervical ganglion in situ. Naunyn-Schmiedebergs Arch. Pharmacol. 281, 145–165 (1974)
Haefely, W., Ruch-Monachon, M.A., Jalfre, M.: Interaction of psychotropic agents with central neurotransmitters as revealed by their effects on PGO waves in the cat. Arzneimittel-Forsch. 26, 1036–1039 (1976)
Haeusler, G., Finch, L.: Vascular reactivity to 5-hydroxytryptamine and hypertension in the rat. Naunyn-Schmiedebergs Arch. Pharmacol. 272, 101–116 (1972)
Haigler, H.J., Aghajanian, G.K.: Mescaline and LSD: Direct and indirect effects on serotonin-containing neurons in brain. Europ. J. Pharmacol. 21, 53–60 (1973a)
Haigler, H.J., Aghajanian, G.K.: A comparison of effects of D-lysergic acid diethylamide (LSD) and serotonin on pre-and postsynaptic cells in the serotonin system. Fed. Proc. 32, 303 (1973b)
Haigler, H.J., Aghajanian, G.K.: Peripheral serotonin antagonists: failure to antagonize serotonin in brain areas receiving a prominent serotonergic input. J. Neural Transm. 35, 257–273 (1974a)
Haigler, H.J., Aghajanian, G.K.: Lysergic acid diethylamide and serotonin: a comparison of effects on serotonergic neurons and neurons receiving serotonergic input. J. Pharmacol. exp. Ther. 188, 688–699 (1974b)
Halaris, A.E., Lovell, R.A.: On the nature of the serotonin binding after LSD. Fed. Proc. 32, 694 (1973)
Halaris, A.E., Freedman, D.X., Fang, V.S.: Plasma corticoids and brain tryptophan after acute and tolerance dosage of LSD. Life Sci. 17, 1467–1472 (1975)
Hall, W.J., O’Connor, P.C.: The action of vasoactive drugs on longitudinal and circular muscle of dog mesenteric vein. J. Pharm. Pharmacol. 25, 109–118 (1973)
Halmagyi, D.F.J., Colebatch, H.J.H.: Serotonin-like cardiorespiratory effects of a serotonin antagonist. J. Pharmacol. exp. Ther. 134, 47–52 (1961)
Hamon, M., Glowinski, J.: Regulation of serotonin synthesis. Life Sci. 15, 1533–1548 (1974)
Hamon, M., Bourgoin, S., Jagger, J., Glowinski, J.: Effects of LSD on synthesis and release of 5-HT in rat brain slices. Brain Res. 69, 265–280 (1974)
Hamon, M., Bourgoin, S., Enjalbert, A., Bockaert, J., Hery, F., Ternaux, J.P., Glowinski, J.: The effect of quipazine on 5-HT metabolism in the rat brain. Naunyn-Schmiedebergs Arch. Pharmacol. 294, 99–108 (1976a)
Hamon, M., Bourgoin, S., Hery, F., Ternaux, J.P.: In vivo and in vitro activation of soluble tryptophan hydroxylase from rat brainstem. Nature (Lond.) 260, 61–63 (1976b)
Handforth, A., Sourkes, T.L.: Inhibition by dopamine agonists of dopamine accumulation following γ-hydroxybutyrate treatment. Europ. J. Pharmacol. 34, 311–319 (1975)
Handschumacher, R.E., Vane, J.R.: Studies relating constrictions to entrance of 5-hydroxytryptamine (5-HT) and tryptamine (T) in smooth muscle. Fed. Proc. 22, 167 (1963)
Handschumacher, R.E., Vane, J.R.: The relationship between the penetration of tryptamine and 5-hydroxytryptamine into smooth muscle and the associated contractions. Brit. J. Pharmacol. 29, 105–118 (1967)
Hardebo, J.E., Edvinsson, L.: Mechanical actions of serotonin and the effect of related inhibitors in intracranial and extracranial vessels. “Headache ‘76”, Joint Meeting of the Italian Headache and the Scandinavian Migraine Societies, Florence, 1976, Abstract, pp. 11–13
Hariri, M.: Uptake of 5-hydroxytryptamine by Mesocestoides corti (Cestoda). J. Parasit. 61, 440–448 (1975)
Harper, M.J.K., Skarnes, R.C.: Inhibition of abortion and fetal death produced by endotoxin or prostaglandin F2α. Prostaglandins 2, 295–309 (1972)
Hauge, A., Lunde, P.K.M., Waaler, B.A.: The effect of bradykinin, kallidin and eledoisin upon the pulmonary vascular bed of an isolated blood-perfused rabbit lung preparation. Acta physiol. scand. 66, 269–277 (1966)
Hayashi, A.: Receptors for phenylephrine and 5-hydroxytryptamine in the rat jejunum. Fukushima J. med. Sci. 21, 59–68 (1975)
Hedqvist, P.: Modulating effect of prostaglandin E2 on noradrenaline release from the isolated cat spleen. Acta physiol. scand. 75, 511–512 (1969)
Hedqvist, P.: Studies on the effect of prostaglandins E1 and E2 on the sympathetic neuromuscular transmission in some animal tissues. Acta physiol. scand. (Suppl.) 345, 1–40 (1970a)
Hedqvist, P.: Control by prostaglandin E2 of sympathetic neurotransmission in the spleen. Life Sci. 9, 269–278 (1970b)
Hedqvist, P.: Dissociation of prostaglandin and a-receptor mediated control of adrenergic transmitter release. Acta physiol. scand. 87, 42A–43A (1973)
Hedqvist, P.: Role of the a-receptor in the control of noradrenaline release from sympathetic nerves. Acta physiol. scand. 90, 158–165 (1974)
Hedqvist, P., Brundin, J.: Inhibition by prostaglandin Ex of noradrenaline release and of effector response to nerve stimulation in the cat spleen. Life Sci. 8, 389–395 (1969)
Hedqvist, P., von Euler, U.S.: Prostaglandin-induced neurotransmission failure in the fieldstimulated, isolated vas deferens. Neuropharmacology 11, 177–187 (1972)
Hedqvist, P., Stjärne, L., Wennmalm, Å.: Inhibition by prostaglandin E2 of sympathetic neurotransmission in the rabbit heart. Acta physiol. scand. 79, 139–141 (1970)
Henderson, G., North, R.A.: Presynaptic action of 5-hydroxytryptamine in the myenteric plexus of the guinea-pig ileum. Brit. J. Pharmacol. 54, 265 (1975)
Hertzler, E.C.: 5-Hydroxytryptamine and transmission in sympathetic ganglia. Brit. J. Pharmacol. 17, 406–413 (1961)
Herxheimer, H.: Further observations on the influence of 5-hydroxytryptamine on bronchial function. J. Physiol. (Lond.) 122, 49P–50P (1953)
Herxheimer, H.: The 5-hydroxytryptamine shock in the guinea-pig. J. Physiol. (Lond.) 128, 435–445 (1955)
Herxheimer, H.: Bronchoconstrictor agents and their antagonists in the intact guinea-pig. Arch. int. Pharmacodyn. 106, 371–380 (1956)
Higgins, W.J.: Intracellular actions of 5-hydroxytryptamine on the bivalve myocardium. J. exp. Zool. 190, 99–109 (1974)
Hillman, G.R., Olsen, N.J., Senft, A.W.: Effect of methysergide and dihydroergotamine on Schistosoma mansoni. J. Pharmacol. exp. Ther. 188, 529–535 (1974)
Hill-Samli, M., MacLeod, R.M.: Thyrotropin-releasing hormone blockade of the ergocryptine and apomorphine inhibition of prolactin release in vitro. Proc. Soc. exp. Biol. (N.Y.) 149, 511–514 (1975)
Hilton, B.P., Cumings, J.N.: An assessment of platelet aggregation induced by 5-hydroxytryptamine. J. clin. Path. 24, 250–258 (1971)
Hirst, G.D.S., McKirdy, H.C.: Synaptic potentials recorded from neurones of the submucous plexus of guinea-pig intestine. J. Physiol. (Lond.) 249, 369–385 (1975)
Hirst, G.D.S., Silinsky, E.M.: Some effects of 5-hydroxytryptamine, dopamine and noradrenaline on neurones in the submucous plexus of guinea-pig small intestine. J. Physiol. (Lond.) 251, 817–832 (1975)
Hitner, H., Di Gregorio, G.J.: Preliminary investigation of the peripheral sympathomimetic effects of phencyclidine. Arch. int. Pharmacodyn. 212, 36–42 (1974)
Hökfelt, T., Fuxe, K.: On the morphology and the neuroendocrine role of the hypothalamic catecholamine neurons. In: Brain-Endocrine Interaction. Median Eminence: Structure and Function, Knigge, K.M., Scott, D.F., Weindt, A. (eds.), pp. 181–223. Basle: Karger 1972
Holgate, J.A., Warner, B.T.: Evaluation of antagonists of histamine, 5-hydroxytryptamine and acetylcholine in the guinea-pig. Brit. J. Pharmacol. 15, 561–566 (1960)
Hollenberg, M.D., Cuatrecasas, P.: Studies on the interaction of hormones with plasma membrane receptors. Biochem. Actions Horm. 3, 41–85 (1975)
Holroyde, M.C., Eyre, P.: Reactivity of isolated bovine mesenteric and hepatic veins to vasoactive agents and specific antigen. Europ. J. Pharmacol. 30, 36–42 (1975)
Holzbauer, M., Vogt, M.: Modification by drugs of the response of the rat’s uterus to adrenaline. Brit. J. Pharmacol. 10, 186–190 (1955)
Hughes, J.: Inhibition of noradrenaline release by lysergic acid diethylamide. Brit. J. Pharmacol. 49, 706–708 (1973)
Hughes, J., Vane, J.R.: An analysis of the responses of the isolated portal vein of the rabbit to electrical stimulation and to drugs. Brit. J. Pharmacol. 30, 46–66 (1967)
Hughes, J., Vane, J.R.: Relaxations of the isolated portal vein of the rabbit induced by nicotine and electrical stimulation. Brit. J. Pharmacol. 39, 476–489 (1970)
Hughes, J., Kosterlitz, H.W., Leslie, F.M.: Effect of morphine on adrenergic transmission in the mouse vas deferens. Assessment of agonist and antagonist potencies of narcotic analgesics. Brit. J. Pharmacol. 53, 371–381 (1975)
Ichimasa, S., Kushiku, K., Furukawa, T.: Pharmacological studies on ganglionic transmission: Influence of antagonists on the catecholamine-induced ganglionic inhibition in the cardiac sympathetic ganglia. Jap. J. Pharmacol. 25 (Suppl.), 20 (1975)
Innes, I.R.: Identification of the smooth muscle excitatory receptors for ergot alkaloids. Brit. J. Pharmacol. 19, 120–128 (1962a)
Innes, I.R.: An action of 5-hydroxytryptamine on adrenaline receptors. Brit. J. Pharmacol. 19, 427–441 (1962b)
Innes, I.R., Kohli, J.D.: Excitatory action of sympathomimetic amines on 5-hydroxytryptamine receptors of gut. Brit. J. Pharmacol. 35, 383–393 (1969)
Iturriza, F.C.: The effect of D-lysergic acid diethylamide on the melanophores of the toad Bufo arenarum under different experimental conditions. Acta endocr. (Kbh.) 48, 322–328 (1965)
Iturriza, F.C., Koch, O.R.: Effect of administration of lysergic acid diethylamide (LSD) on the colloid vesicles of the pars intermedia of the toad pituitary. Endocrinology 75, 615–616 (1964)
Iversen, L.L.: The inhibition of noradrenaline uptake by drugs. In: Advances in Drug Research. Harper, N.J., Simmonds, A.B. (eds.), pp. 1–46. London-New York: Academic Press 1965
Iversen, L.L.: The uptake and storage of noradrenaline in sympathetic nerves. Cambridge: University Press 1967
Iversen, L.L.: Catecholamine uptake processes. Brit. med. Bull. 29, 130–135 (1973)
Jacoby, J.H., Shabshelowitz, H., Fernstrom, J.D., Wurtman, R.J.: The mechanism by which methiothepin, a putative serotonin receptor antagonist, increases brain 5-hydroxyindole levels. J. Pharmacol. exp. Ther. 195, 257–264 (1975)
Jafferji, S.S., Michell, R.H.: Stimulation of phosphatidylinositol turnover by histamine, 5-hydroxytryptamine and adrenaline in the longitudinal smooth muscle of guinea-pig ileum. Biochem. Pharmacol. 25, 1429–1430 (1976)
Jalfre, M., Monachon, M.-A., Haefely, W.: Pharmacological modifications of benzoquinolizine-induced geniculate spikes. Experientia (Basel) 26, 691 (1970)
Jalfre, M., Monachon, M.A., Haefely, W.: Drugs and PGO waves in the cat. In: First Can. Int. Symposium of Sleep. McClure, D.J. (ed.), pp. 155–185. Montreal: Roche Scientific Service 1972
Jalfre, M., Ruch-Monachon, M.-A., Haefely, W.: Methods for assessing the interaction of agents with 5-hydroxytryptamine neurons and receptors in the brain. Adv. Biochem. Psychopharmacol. 10, 121–134 (1974)
Jang, C.S.: The potentiation and paralysis of adrenergic effects by ergotoxine and other substances. J. Pharmacol. exp. Ther. 71, 87–94 (1941)
Jaques, R., Bein, H.J., Meier, R.: 5-Hydroxytryptamine antagonists, with special reference to the importance of sympathomimetic amines and isopropyl-noradrenaline. Helv. physiol. Pharmacol. Acta 14, 269–278 (1956)
Jasmin, G., Bois, P.: Effect of various agents on the development of kidney infarcts in rats treated with serotonin. Lab. Invest. 9, 503–513 (1960)
Jenkinson, D.H., Morton, I.K.M.: Adrenergic blocking drugs as tools in the study of the actions of catecholamines on the smooth muscle membrane. Ann. N.Y. Acad. Sci. 139, 762–771 (1967a)
Jenkinson, D.H., Morton, I.K.M.: The effect of noradrenaline on the permeability of depolarized intestinal smooth muscle to inorganic ions. J. Physiol. (Lond.) 188, 373–386 (1967b)
Jenkinson, D.H., Morton, I.K.M.: The role of α-and β-adrenergic receptors in some actions of catecholamines on intestinal smooth muscle. J. Physiol. (Lond.) 188, 387–402 (1967c)
Joiner, P.D., Kadowitz, P.J., Davis, L.B., Hyman, A.L.: Contractile responses of canine isolated intrapulmonary arteries (IPA) and veins (IPV) to norepinephrine (NE), serotonin (5-HT) and tyramine (TYR). Pharmacologist 16, 299 (1974)
Joiner, P.D., Kadowitz, P.J., Davis, L.B., Hyman, A.L.: Contractile responses of canine isolated pulmonary lobar arteries and veins to norepinephrine, serotonin and tyramine. Canad. J. Physiol. Pharmacol. 53, 830–838 (1975)
Kahn, C.R.: Membrane receptors for hormones and neurotransmitters. J. Cell Biol. 70, 261–286 (1976)
Kahr, H., Fischer, W.: Die Wirkung des 5-Oxtryptamins auf das Pigmentsystem der Haut. Klin. Wschr. 35, 41–44 (1957)
Kalbermatten, J.P. de: Effet de la sérotonine sur l’hypersensibilité de dénervation du ganglion sympathique cervical isolé du rat. Helv. physiol. pharmacol. Acta 20, 294–315 (1962)
Karlsberg, P., Adams, J.E., Elliott, H.W.: Inhibition and reversal of serotonin-induced cerebral vasospasm. Surg. Forum 13, 425–427 (1962)
Karlsberg, P., Elliott, H.W., Adams, J.E.: Effects of various pharmacologic agents on cerebral arteries. Neurology (Minneap.) 13, 772–778 (1963)
Katsuragi, T., Suzuki, T.: Methysergide-induced potentiation of the cholinergic response of the guinea-pig vas deferens. Jap. J. Pharmacol. 24 (Suppl.), 145 (1974)
Katz, R.I., Kopin, I.J.: Effect of D-LSD and related compounds on release of norepinephrine-H3 and serotonin-H3 evoked from brain slices by electrical stimulation. Pharmacol. Res. Commun. 1, 54–62 (1969)
Kawai, N.: Release of 5-hydroxytryptamine from slices of superior colliculus by optic tract stimulation. Neuropharmacology 9, 395–397 (1970)
Kawai, N., Yamamoto, C.: Antagonism between serotonin and LSD studied in vitro in thin sections from the superior colliculus of guinea-pig. Brain Res. 7, 325–328 (1968)
Kawai, N., Yamamoto, C.: Effects of 5-hydroxytryptamine, LSD and related compounds on electrical activities evoked in vitro in thin sections from the superior colliculus. Int. J. Neuropharmacol. 8, 437–449 (1969)
Kelly, M.J.: Receptors for dopamine in some isolated vascular tissues of the dog. Brit. J. Pharmacol. 46, 575P–577P (1972)
Kerkut, G.A., Laverack, M.S.: A cardio-accelerator present in tissue extracts of the snail Helix aspersa. Comp. Biochem. Physiol. 1, 62–71 (1960)
Khairallah, P.A., Page, I.H., Türker, R.K.: Some properties of prostaglandin E1 action on muscle. Arch. int. Pharmacodyn. 169, 328–341 (1967)
Kimura, M., Waki, I., Tamura, H.: Actions of dibenamine on adrenergic β-receptors in cat’s papillary muscle (Molecular pharmacological studies on drug-receptor interaction systems in drug action IX). Jap. J. Pharmacol. 20, 16–22 (1970)
King, T.O.: Hydroxytryptamine. The antagonism of its broncho-constrictor action. Int. Physiologenkongress, Brüssel, August 1956, p. 499
King, T.O.: The antagonism of 5-hydroxytryptamine pneumoconstriction. Arch. int. Pharmacodyn. 110, 71–76 (1957)
King, A.R., Martin, I.L., Melville, K.A.: Reversal learning enhanced by lysergic acid diethylamide (LSD): concomitant rise in brain 5-hydroxytryptamine levels. Brit. J. Pharmacol. 52, 419–425 (1974)
Kirpekar, S.M., Cervoni, P.: Effect of cocaine, phenoxybenzamine and phentolamine on the catecholamine output from spleen and adrenal medulla. J. Pharmacol. exp. Ther. 142, 59–70 (1963)
Kirpekar, S.M., Puig, M.: Effect of flow-stop on noradrenaline release from normal spleens and spleens treated with cocain, phentolamine or phenoxybenzamine. Brit. J. Pharmacol. 43, 359–369 (1971)
Klawans, Jr., H.L., Goetz, C., Weiner, W.J.: 5-Hydroxytryptophan-induced myoclonus in guinea-pigs and the possible role of serotonin in infantile myoclonus. Neurology (Minneap.) 23, 1234–1240 (1973)
Klawans, H.L., D’Amico, D.J., Patel, B.C.: Behavioral supersensitivity to 5-hydroxytryptophan induced by chronic methysergide pretreatment. Psychopharmacologia 44, 297–300 (1975)
Klinge, E., Sjöstrand, N.O.: Contraction and relaxation of the retractor penis muscle and the penile artery of the bull. Acta physiol. scand. (Suppl.) 420, 1–88 (1974)
Kohli, J.D.: Receptors for sympathomimetic amines in the rabbit aorta: Differentiation by specific antagonists. Brit. J. Pharmacol. 32, 273–279 (1968)
Kohli, J.D.: A comparative study of dopamine and noradrenaline on the rabbit aorta. Canad. J. Physiol. Pharmacol. 47, 171–174 (1969)
Kohli, J.D., Innes, I.R.: Differentiation between norepinephrine (NE) and 5-hydroxytryptamine (5-HT) receptors in vascular smooth muscle with 2-bromo-lysergic acid diethylamide (BOL). Pharmacologist 6, 207 (1964)
Komiskey, H.L., Rudy, T.A.: The involvement of methysergide-sensitive receptors and prostaglandins in the hyperthermia evoked by 5-HT in the cat. Res. Commun. Chem. Path. Pharmacol. 11, 195–208 (1975)
Konzett, H.: The effects of 5-hydroxytryptamine and its antagonists on tidal air. Brit. J. Pharmacol. 11, 289–294 (1956)
Konzett, H.: Specific antagonism of dibenamine to ergometrine. In: Ciba Foundation Symposium on Adrenergic Mechanisms. Wolstenholme, G.E.W., O’Connor, M. (eds.), pp. 463–465. London: J. and A. Churchill 1960
Kopin, I.J.: V. Interaction between the drugs and brain amines. Neurosci. Res. Prog. Bull. 8, 27–32 (1970)
Kostowski, W., Giacalone, E.: Effect of psychotropic drugs on the release of serotonin induced by electrical stimulation of midbrain raphe in rats. In: The Present Status of Psychotropic Drugs. Cerletti, A., Bove, F.J. (eds.), pp. 289–291. Amsterdam: Excerpta Medica Foundation 1969
Kostowski, W., Gumulka, W., Jerlicz, M.: The effects of serotonin injections into the locus coeruleus on ponto geniculo occipital (PGO) waves and cortical EEG pattern in cats. Pol. J. Pharmacol. Pharm. 27, 127–137 (1975)
Krishnamurty, V.S.R.: Receptors for sympathomimetic amines and 5-hydroxytryptamine in the rat aorta. Arch. int. Pharmacodyn. 189, 90–99 (1971)
Krivoy, W. A.: The preservation of substance P by lysergic acid diethylamide. Brit. J. Pharmacol. 12, 361–364 (1957)
Krnjević, K., Phillis, J.W.: Actions of certain amines on cerebral cortical neurones. Brit. J. Pharmacol. 20, 471–490 (1963a)
Krnjević, K., Phillis, J.W.: Iontophoretic studies of neurones in the mammalian cerebral cortex. J. Physiol. (Lond.) 165, 274–304 (1963b)
Kuhar, M.J., Roth, R.H., Aghajanian, G.K.: Selective reduction of tryptophan hydroxylase activity in rat forebrain after midbrain raphe lesions. Brain Res. 35, 167–176 (1971)
Kuhar, M.J., Aghajanian, G.K., Roth, R.H.: Tryptophan hydroxylase activity and synaptosomal uptake of serotonin in discrete brain regions after midbrain lesions: correlations with serotonin levels and histochemical fluorescence. Brain Res. 44, 165–176 (1972a)
Kuhar, M.J., Roth, R.H., Aghajanian, G.K.: Synaptosomes from forebrains of rats with midbrain raphe lesions: selective reductions of serotonin uptake. J. Pharmacol. exp. Ther. 181, 36–45 (1972b)
Langer, S.Z., Enero, M.A., Adler-Graschinsky, E., Dubocovich, M.L., Celuchi, S.M.: Presynaptic regulatory mechanisms for noradrenaline release by nerve stimulation. In: Central Action of Drugs in Blood Pressure Regulation. Davies, D.S., Reid, J.L. (eds.), pp. 133–150. Kent: Pitman Medical Publishing 1975
Lecomte, J.: Sensibilisation à l’adrénaline par la 5-hydroxytryptamine. Arch. int. Physiol. Biochim. 61, 84–85 (1953)
Legge, K.F., Randic, M., Straughan, D.W.: The pharmacology of neurones in the pyriform cortex. Brit. J. Pharmacol. 26, 87–107 (1966)
Leitch, J.L., Liebig, C.S., Haley, T.J.: The use of the rat’s isolated seminal vesicle for the assay of sympatholytic drugs. Brit. J. Pharmacol. 9, 236–239 (1954)
Leonard, B.E., Liska, K.J.: Effects of morpholino-, pyrrolidino-, piperizino-, and cyclooctylderivatives of beta-alanine on brain amines and amino acids. Life Sci. 10, 93–104 (1971)
Levy, B., Ahlquist, R.P.: An analysis of adrenergic blocking activity. J. Pharmacol. exp. Ther. 133, 202–210 (1961)
Levy, B., Tozzi, S.: The adrenergic receptive mechanism of the rat uterus. J. Pharmacol. exp. Ther. 142, 178–184 (1963)
Levy, B., Wilkenfeld, E.: The actions of selective β-receptor antagonists on the guinea-pig trachea. Europ. J. Pharmacol. 11, 67–74 (1970)
Levy, J., Michel-Ber, E.: Contribution à l’action pharmacologique exercée par la sérotonine sur quelques organes isolés (intestine et oreillette). J. Physiol. (Paris) 48, 1051–1084 (1956)
Liao, S.: Cellular receptors and mechanisms of action of steroid hormones. Int. Rev. Cytol. 41, 87–172 (1975)
Liebeswar, G., Goldman, J.E., Koester, J., Mayeri, E.: Neural control of circulation in Aplysia. III. Neurotransmitters. J. Neurophysiol. 38, 767–779 (1975)
Lin, R.C., Ngai, S.H., Costa, E.: Lysergic acid diethylamide: role in conversion of plasma tryptophan to brain serotonin (5-hydroxytryptamine). Science 166, 237–239 (1969)
Lingjaerde, O. Jr.: Effects of ergotamine and dihydroergotamine on uptake of 5-hydroxytryptamine in blood platelets. Europ. J. Pharmacol. 13, 76–82 (1970)
Little, K.D., DiStefano, V., Leary, D.E.: LSD and serotonin effects on spinal reflexes in the cat. J. Pharm. exp. Ther. 119, 161 (1957)
Loew, D.M., Depoortere, H., Buerki, H.R.: Effects of dihydrogenated ergot alkaloids on the sleep-wakefulness cycle and on brain biogenic amines in the rat. Arzneimittel-Forsch. 26, 1080–1083 (1976)
Loew, E.R., Kaiser, M.E., Moore, V.: Effect of various drugs on experimental asthma produced in guinea-pig by exposure to atomized histamine. J. Pharm. exp. Ther. 86, 1–6 (1946)
Loewi, O., Navratil, E.: Über humorale Übertragbarkeit der Herznervenwirkung. XI. Über den Mechanismus der Vaguswirkung von Physostigmin und Ergotamin. Pflügers Arch. 214, 689–696 (1926)
Lovell, R.A., Freedman, D.X.: Stereospecific receptor sites for D-lysergic acid diethylamide in rat brain: Effects of neurotransmitters, amine antagonists, and other psychotropic drugs. Molec. Pharmacol. 12, 620–630 (1976)
Lovell, R.A., Rosecrans, J.A., Freedman, D.X.: Effects of LSD on rat brain serotonin metabolism. Fed. Proc. 26, 708 (1967)
Ludány, G., Gáti, T., Szabó, St., Hideg, J.: 5-Hydroxytryptamin (Enteramin, Serotonin) und die Darmzottenbewegung. Arch. int. Pharmacodyn. 118, 62–69 (1959)
Lum, B.K.B., Kermani, M.H., Heilman, R.D.: Intestinal relaxation produced by sympathomimetic amines in the isolated rabbit jejunum: selective inhibition by adrenergic blocking agents and by cold storage. J. Pharmacol. exp. Ther. 154, 463–471 (1966)
McCulloch, M.W., Rand, M.J., Story, D.F.: Inhibition of 3H-noradrenaline release from sympathetic nerves of guinea-pig atria by a presynaptic α-adrenoceptor mechanism. Brit. J. Pharmacol. 46, 523P–524P (1972)
MacLeod, R.M., Lehmeyer, J.E.: Regulation of the synthesis and release of prolactin. In: Lactogenic Hormones. Wolstenholme, G.E.W., Knight, J. (eds.). A Ciba Foundation Symposium, pp. 53–76. Edinburgh-London: Churchill Livingstone 1972
MacLeod, R.M., Lehmeyer, J.E.: Studies on the mechanism of the dopamine-mediated inhibition of prolactin secretion. Endocrinology 94, 1077–1085 (1974)
Magistretti, M., Valzelli, L.: Ricerche sulla attività inotropa della serotonina sull’orecchietta e sul cuore isolati. Boll. Soc. ital. Biol. sper. 31, 1035–1037 (1955)
Malanga, C.J.: Dopaminergic responses by gill cilia of bivalve molluscs. Fed. Proc. 32, 691 (1973)
Malanga, C.J.: Dopaminergic stimulation of ciliary activity in the gill of the bivalve mollusc, Mytilus edulis. Fed. Proc. 33, 551 (1974)
Maling, H.M., Webster, M.E., Williams, M.A., Saul, W., Anderson, W., Jr.: Inflammation induced by histamine, serotonin, bradykinin and compound 48/80 in the rat: antagonists and mechanisms of action. J. Pharmacol. exp. Ther. 191, 300–310 (1974)
Malorny, G., Orzechowski, G.: Untersuchungen liber die Wirkungsweise der Sympathicomimetica. III. Über die ephedrinahnliche Wirkung der Secalealkaloide Ergotamin und Ergometrin. Naunyn-Schmiedebergs Arch. Pharmacol. 196, 253–259 (1940)
Mansour, T.E.: Effect of lysergic acid diethylamide, serotonin and related compounds on a parasitic trematode, Fasciola hepatica. Fed. Proc. 15, 454–455 (1956)
Mansour, T.E.: The effect of lysergic acid diethylamide, 5-hydroxytryptamine, and related compounds on the liver fluke, Fasciola hepatica. Brit. J. Pharmacol. 12, 406–409 (1957)
Mansour, T.E., Lago, A.D., Hawkins, J.L.: Occurrence and possible role of serotonin in Fasciola hepatica. Fed. Proc. 16, 319 (1957)
Mansour, T.E., Sutherland, E.W., Rail, T.W., Bueding, E.: The effect of serotonin (5-hydroxytryptamine) on the formation of adenosine 3′,5′-phosphate by tissue particles from the liver fluke, Fasciola hepatica. J. biol. Chem. 235, 466–470 (1960)
Marchbanks, R.M.: Serotonin binding to nerve ending particles and other preparations from rat brain. J. Neurochem. 13, 1481–1493 (1966)
Marchbanks, R.M.: Inhibitory effects of lysergic acid derivatives and reserpine on 5-HT binding to nerve ending particles. Biochem. Pharmacol. 16, 1971–1979 (1967)
Marchbanks, R.M., Rosenblatt, F., O’Brien, R.D.: Serotonin binding to nerve-ending particles of the rat brain and its inhibition by lysergic acid diethylamide. Science 144, 1135–1137 (1964)
Markstein, R., Wagner, H.: The effect of dihydroergotoxin, phentolamine and pindolol on catecholamine-stimulated adenylcyclase in rat cerebral cortex. F.E.B.S. Lett. 55, 275–277 (1975)
Markstein, R., Wagner, H.: Effect of dihydroergotoxine on cyclic AMP generating systems in rat cerebral cortex slices. Gerontology 24 (Suppl. I), 94–105 (1978)
Markstein, R. et al.: unpublished results 1976
Marley, E., Vane, J.R.: Tryptamines and spinal cord reflexes in cats. Brit. J. Pharmacol. 31, 447–465 (1967)
Marley, E., Whelan, J.E.: Some unexpected pharmacological effects of p-chlorophenylalanine methyl ester (PCPA methyl ester). Brit. J. Pharmacol. 52, 133P–134P (1974)
Marley, E., Whelan, J.E.: Some pharmacological effects of p-chlorphenylalanine unrelated to tryptophan hydroxylase inhibition. Brit. J. Pharmacol. 56, 133–144 (1976)
Marrazzi, A.S.: The effects of certain drugs on cerebral synapses. Ann. N.Y. Acad. Sci. 66, 496–507 (1957)
Marrazzi, A.S., Hart, E.R.: Evoked cortical responses under the influence of hallucinogens and related drugs. Electroencephalogr. Clin. Neurophysiol. 7, 146 (1955a)
Marrazzi, A.S., Hart, E.R.: Relationship of hallucinogens to adrenergic cerebral neurohumors. Science 121, 365–367 (1955b)
Martin, W.R., Eades, C.G.: The action of tryptamine on the dog spinal cord and its relationship to the agonistic actions of LSD-like psychotogens. Psychopharmacologia 17, 242–257 (1970)
Matin, M.A., Vijayvargiya, R.: Chlorpromazine-lysergic acid diethylamide antagonism. J. Pharm. Pharmacol. 19, 192–193 (1967)
Matthes, K.: The action of blood on acetylcholine. J. Physiol. (Lond.) 70, 338–348 (1930)
Maurer, R., Grieder, A.: Effects of dihydroergotamine on cAMP content in cultured glial cells. Experientia (Basel) 31, 730–731 (1975)
Mawson, C., Whittington, H.: Evaluation of the peripheral and central antagonistic activities against 5-hydroxytryptamine of some new agents. Brit. J. Pharmacol. 39, 223P (1970)
Mchedlishvili, G.I., Ormotsadze, L.G.: Experimental models of spasm of the internal carotid artery. Pat. Fiziol. eksp. Ter. 5, 79–81 (1974)
Mena, M.A., Vidrio, H.: On the mechanism of the coronary dilator effect of serotonin in the dog. Europ. J. Pharmacol. 36, 1–5 (1976)
Mendez, R.: Antagonism of adrenaline by ergotamine. J. Pharmacol. 32, 451–464 (1928)
Metcalfe, H.L., Turner, P.: Pharmacological studies of cinanserin in human isolated smooth muscle. Brit. J. Pharmacol. 37, 519P (1969)
Metcalfe, H.L., Turner, P.: A comparison of the effects of cinanserin and methysergide on responses of isolated smooth muscle to acetylcholine. Arch. int. Pharmacodyn. 183, 148–158 (1970)
Meyer, D.K., Abele, M., Hertting, G.: Influence of serotonin on water intake and the reninangiotensin system in the rat. Arch. int. Pharmacodyn. 212, 130–140 (1974)
Michal, F.: D-receptor for serotonin on blood platelets. Nature (Lond.) 221, 1253–1254 (1969)
Michal, F., Motamed, M.: Time-dependent potentiation and inhibition by 5-hydroxytryptamine of platelet aggregation induced by ADP. Brit. J. Pharmacol. 54, 221–222 (1975)
Michal, F., Motamed, M.: Shape change and aggregation of blood platelets: interaction between the effects of adenosine diphosphate, 5-hydroxytryptamine and adrenaline. Brit. J. Pharmacol. 56, 209–218 (1976)
Mielke, H., Seiler, K.-U., Stumpf, U., Wassermann, O.: Über eine Beziehung zwischen dem Serotoninstoffwechsel und der pulmonalen Hypertonic bei Ratten nach Gabe verschiedener Anorektika. Z. Kardiol. 62, 1090–1098 (1973)
Mills, D.C.B., Roberts, G.C.K.: Effects of adrenaline on human blood platelets. J. Physiol. (Lond.) 193, 443–453 (1967)
Mitchell, J.R.A., Sharp, A.A.: Platelet clumping in vitro. Brit. J. Haematol. 10, 78–93 (1964)
Mörsdorf, K., Bode, H.H.: Zur Beeinflussung der Permeabilitatssteigernden Wirkung des Serotonins durch verschiedenartige Pharmaka. Arch. int. Pharmacodyn. 118, 292–297 (1959)
Monachon, M.-A., Burkhard, W.P., Jalfre, M., Haefely, W.: Blockade of central 5-hydroxytryptamine receptors by methiothepin. Naunyn-Schmiedebergs Arch. Pharmacol. 274, 192–197 (1972)
Mosko, S., Jacobs, B.L.: Effect of peripherally administered serotonin on the neuronal activity of midbrain raphe neurons. Brain Res. 79, 315–320 (1974)
Mouton, Y., Demaille, A.: La barriere capillaire du mesentere de rat ayant recu une injection intravasculaire d’hepatome ascitique de Zajdela. III. Influence de la sérotonine et de l’histamine sur l’extravasation tumorale. C. R. Soc. Biol. (Paris) 169, 974–978 (1975)
Müller-Schweinitzer, E.: Investigations on the mode of action of dihydroergotamine in human saphenous and dog saphenous and femoral veins. Naunyn-Schmiedebergs Arch. Pharmacol. 279 (Suppl.), R44 (1973)
Müller-Schweinitzer, E.: Further studies on the mode of action of ergotamine on canine vein strips. Naunyn-Schmiedebergs Arch. Pharmacol. 282 (Suppl.), R68 (1974a)
Müller-Schweinitzer, E.: Enhanced synthesis of prostaglandin-like substance(s) contributes to the mode of action of dihydroergotamine. Naunyn-Schmiedebergs Arch. Pharmacol. 285 (Suppl.), R57 (1974b)
Müller-Schweinitzer, E.: Studies on the peripheral mode of action of dihydroergotamine in human and canine veins. Europ. J. Pharmacol. 27, 231–237 (1974c)
Müller-Schweinitzer, E.: Differentiation between serotonin-and alpha-adrenoceptor blocking agents in isolated canine saphenous arteries. Naunyn-Schmiedebergs Arch. Pharmacol. 287 (Suppl.), R21 (1975a)
Müller-Schweinitzer, E.: unpublished results 1975 b
Müller-Schweinitzer, E.: Responsiveness of isolated canine cerebral and peripheral arteries to ergotamine. Naunyn-Schmiedebergs Arch. Pharmacol. 292, 113–118 (1976a)
Müller-Schweinitzer, E.: Evidence for stimulation of 5-HT receptors in canine saphenous arteries by ergotamine. Naunyn-Schmiedebergs Arch. Pharmacol. 295, 41–44 (1976b)
Müller-Schweinitzer, E.: Comparative studies on the mode of action of ergotamine in canine and human arteries. “Headache ‘76”, Joint Meeting of the Italian Headache and the Scandinavian Migraine Societies, Florence, 1976c, Abstract, pp. 22–23
Müller-Schweinitzer, E.: Comparative studies on the mode of action of ergotamine in canine and human arteries. In: Proceedings of “Headache ‘76”. Torino: C.G. Edizioni Medico-Scientifico 1976d (in press)
Müller-Schweinitzer, E., Brundell, J.: Enhanced prostaglandin synthesis contributes to the venoconstrictor activity of ergotamine. Blood Vessels 12, 193–205 (1975a)
Müller-Schweinitzer, E., Brundell, J.: Modification of canine vascular smooth muscle responses to dihydroergotamine by endogenous prostaglandin synthesis. Europ. J. Pharmacol. 34, 197–206 (1975b)
Müller-Schweinitzer, E., Stürmer, E.: Investigations on the mode of action of ergotamine in the isolated femoral vein of the dog. Experientia (Basel) 28, 743 (1972)
Müller-Schweinitzer, E., Stürmer, E.: Investigations on the mode of action of ergotamine in the isolated femoral vein of the dog. Brit. J. Pharmacol. 51, 441–446 (1974a)
Müller-Schweinitzer, E., Stürmer, E.: Studies on the mechanism of the venoconstrictor activity of ergotamine on isolated canine saphenous veins. Blood Vessels 11, 183–190 (1974b)
Müller-Schweinitzer, E., Stürmer, E.: Effects of ergotamine on the responses of isolated saphenous and external carotid arteries of the dog to noradrenaline and serotonin: Sixth Internat. Congress Pharmacol., Helsinki, 1975, Abstract 1555
Mulder, A.H., Stoof, J.C., Tilders, F.J.H.: Depolarization-induced release of central neurotransmitters from rat brain synaptosomes embedded in sephadex G-15 in a superfusion system. Sixth Internat. Congress Pharmacol., Helsinki, 1975, Abstract 1118
Munday, K.A., Poat, J.A., Woodruff, G.N.: Structure activity studies on dopamine receptors, a comparison between rat striatal adenylate cyclase and Helix aspersa neurones. Brit. J. Pharmacol. 57, 452P–453P (1976)
Nair, X.: Contractile responses of guinea-pig umbilical arteries to various hallucinogenic agents. Res. Commun. Chem. Path. Pharmacol. 9, 535–542 (1974)
Nair, X., Dyer, D.C.: Responses of guinea-pig umbilical vasculature to vasoactive drugs. Europ. J. Pharmacol. 27, 294–304 (1974)
Nakanishi, H., Takeda, H.: The possible role of adenosine triphosphate in chemical transmission between the hypogastric nerve ending and seminal vesicle in the guinea-pig. Jap. J. Pharmacol. 23 (Suppl.), 19 (1973a)
Nakanishi, H., Takeda, H.: The possible role of adenosine triphosphate in chemical transmission between the hypogastric nerve terminal and seminal vesicle in the guinea-pig. Jap. J. Pharmacol. 23, 479–490 (1973b)
Nakano, J.: Effects of prostaglandins E1, A1 and F2α on the coronary and peripheral circulations. Proc. Soc. exp. Biol. (N.Y.) 127, 1160–1163 (1968)
Nanda, T.C.: The action of ergotamine on the response of the rabbit’s gut to adrenaline. J. Pharmacol. exp. Ther. 42, 9–16 (1931)
Narebski, J., Romanowski, W., Kadziella, W.: Effect of 1-methyl-d-lysergic butanolamide (Deseril) on EEG changes due to 5-hydroxytryptamine and 5-hydroxytryptophane. Acta physiol. pol. 14, 157–170 (1963)
Nathanson, J.A., Greengard, P.: Serotonin-sensitive adenylate cyclase in neural tissue and its similarity to the serotonin receptor: a possible site of action of lysergic acid diethylamide. Proc. natl. Acad. Sci. (Wash.) 71, (3) 797–801 (1974)
Navratil, E.: Über die Beeinflussung der Cholinesterase durch Ergobasin. Klin. Wschr. 2, 64–65 (1937)
Ng, K.Y., Chase, T.N., Kopin, I.J.: Drug-induced release of 3H-norepinephrine and 3H-serotonin from brain slices. Nature (Lond.) 228, 468–469 (1970)
Nielsen, K.C., Owman, C.: Contractile response and amine receptor mechanisms in isolated middle cerebral artery of the cat. Brain Res. 27, 33–42 (1971)
Nilsson, S.: Adrenergic innervation and drug responses of the oval sphincter in the swimbladder of the cod Gadus morhua. Acta physiol. scand. 83, 446–453 (1971)
Nishi, K.: The action of 5-hydroxytryptamine on chemoreceptor discharges of the cat’s carotid body. Brit. J. Pharmacol. 55, 27–40 (1975)
North, R.A., Henderson, G.: Action of morphine on guinea-pig myenteric plexus and mouse vas deferens studied by intracellular recording. Life Sci. 17, 63–66 (1975)
O’Brien, J.R.: A comparison of platelet aggregation produced by seven compounds and a comparison of their inhibitors. J. clin. Path. 17, 275–281 (1964)
Offermeier, J., Ariens, E.J.: Serotonin. I. Receptors involved in its action. Arch. int. Pharmacodyn. 164, 192–215 (1966)
Ogle, C.W., Wong, C.Y.: The inhibitory and excitatory properties of alpha adrenoceptors in the rat stomach. Life Sci. 10, 153–159 (1971)
O’Malley, B.W., Hardman, J.G.: Hormon action, part A: steroid hormones. Methods Enzymol. 36, 135–411 (1975)
Osborne, N.N., Hiripi, L., Neuhoff, V.: The in vitro uptake of biogenic amines by snail Helix pomatia nervous tissue. Biochem. Pharmacol. 24, 2141–2148 (1975)
Osswald, W., Guimarães, S.: Über den Mechanismus der Isoprenalinumkehr. Naunyn-Schmiedebergs Arch. Pharmacol. 243, 1–15 (1962)
Osswald, W., Guimarães, S., Garret, J.: Influence of propranolol and ICI 50.172 on the cardiovascular actions of catecholamines as modified by ergotamine. J. Pharmacol. exp. Ther. 174, 315–322 (1970)
Owen, D.A.A., Herd, J.K., Kalberer, F., Pacha, W., Salzmann, R.: The influence of ergotamine and methysergide on the storage of biogenic amines. Headache 11, 91–92 (1971a)
Owen, D.A.A., Herd, J.K., Kalberer, F., Pacha, W., Salzmann, R.: The influence of ergotamine and methysergide on the storage of biogenic amines. In: Proc. Intern. Headache Symposium, Elsinore, Denmark. Dalessio, D.J., Dalsgaard-Nielson, T., Diamond, S. (eds.), pp. 153–161. Basle: Sandoz 1971b
Paasonen, M.K., Giarman, N.J.: Brain levels of 5-hydroxytryptamine after various agents. Arch. int. Pharmacodyn. 114, 189–200 (1958)
Pacha, W., Salzmann, R.: Inhibition of the re-uptake of neuronally liberated noradrenaline and α-receptor blocking action of some ergot alkaloids. Brit. J. Pharmacol. 38, 439P–440P (1970)
Palmer, G.C., Burks, T.F.: Central and peripheral adrenergic blocking actions of LSD and BOL. Europ. J. Pharmacol. 16, 113–116 (1971)
Panigel, M.: Contribution à la physiologie de la circulation foeto-placentaire. I. Etude de la vaso-motricité des artères du cordon ombilical humain. J. Physiol. (Paris) 51, 941–969 (1959)
Panigel, M.: Placental perfusion experiments. Amer. J. Obstet. Gynec. 84, 1664–1683 (1962)
Parker, G.H.: The responses of catfish melanophores to ergotamine. Biol. Bull. 81, 163–167 (1941)
Parmley, W. W., Rabinowitz, B., Chuck, L.: The role of alpha adrenergic receptors in mediating positive inotropic effects in ventricular myocardium. Amer. J. Cardiol. 33, 161 (1974)
Parratt, J.R., West, G.B.: Inhibition of oedema production in the rat. J. Physiol. (Lond.) 135, 24P–25P (1957a)
Parratt, J.R., West, G.B.: 5-Hydroxytryptamine and the anaphylactoid reaction in the rat. J. Physiol. (Lond.) 139, 27–41 (1957b)
Parratt, J.R., West, G.B.: Inhibition by various substances of oedema formation in the hind-paw of the rat induced by 5-hydroxytryptamine, histamine, dextran, eggwhite and compound 48/80. Brit. J. Pharmacol. 13, 65–70 (1958)
Passow, H., Schniewind, H., Weiss, C.: Die Wirkung von 5-Hydroxytryptamin auf das Gefäßsystem der isolierten Rattenniere. Naunyn-Schmiedebergs Arch. Pharmacol. 240, 179–186 (1960)
Paterson, G.: The response to transmural stimulation of isolated arterial strips and its modification by drugs. J. Pharm. Pharmacol. 17, 341–349 (1965)
Patten, B.M., Oliver, K.L., Engel, W.K.: Serotonin-induced muscle weakness. Arch. Neurol. (Chic.) 31, 347–349 (1974)
Paul, S.M., Halaris, A.E.: Rat brain de-acetylating activity: Stereospecific inhibition by LSD and serotonin-related compounds. Biochem. biophys. Res. Commun. 70, 207–211 (1976)
Paul, S.M., Halaris, A.E., Freedman, D.X., Hsu, L.L.: Rat brain aryl acylamidase: Stereospecific inhibition by LSD and serotonin-related compounds. J. Neurochem. 27, 625–627 (1976)
Pert, C.B., Snyder, S.H.: Properties of opiate-receptor binding in rat brain. Proc. natl. Acad. Sci. (Wash.) 70, 2243–2247 (1973)
Peters, D.A.V.: Comparison of the chronic and acute effects of D-lysergic acid diethylamide (LSD) treatment on rat brain serotonin and norepinephrine. Biochem. Pharmacol. 23, 231–237 (1974a)
Peters, D.A.V.: Chronic lysergic acid diethylamide administration and serotonin turnover in various regions of rat brain. J. Neurochem. 23, 625–628 (1974b)
Pfeifer, Y., Sadowsky, E., Sulman, F.G.: Prevention of serotonin abortion in pregnant rats by five serotonin antagonists. Obstet. Gynecol. 33, 709–714 (1969)
Phillis, J.W., Tebecis, A.K., York, D.H.: The inhibitory action of monoamines on lateral geniculate neurones. J. Physiol. (Lond.) 190, 563–581 (1967)
Pichler, E., Lazarini, W., Filippi, R.: Über schraubenförmige Struktur von Arterien. II. Mitteilung: Pharmakologische Strukturanalyse von Hirnarterien. Naunyn-Schmiedebergs Arch. Pharmacol. 219, 420–439 (1953)
Pichler, E., Ostfeld, A.M., Goodell, H., Wolff, H.G.: Studies on headache: Central versus peripheral action of ergotamine tartrate and its relevance to the therapy of migraine headache. Arch. Neurol. Psychiat. (Chic.) 76, 571–577 (1956)
Pijnenburg, A.J.J., van Rossum, J.M.: Stimulation of locomotor activity following injection of dopamine into the nucleus accumbens. J. Pharm. Pharmacol. 25, 1003–1004 (1973)
Pijnenburg, A.J.J., Woodruff, G.N., van Rossum, J.M.: Ergometrine induced locomotor activity following intracerebral injection into the nucleus accumbens. Brain Res. 59, 289–302 (1973)
Pik, K., Borsy, J.: The mechanism of action of GYKI-32084, a new antiserotonin agent. Naunyn-Schmiedebergs Arch. Pharmacol. 284 (Suppl.), R62 (1974)
Pitzele, S., Dobell, A.R.C.: Inhibition of serotonin-induced blood cell aggregation in the dog. Surgery 73, 416–422 (1973)
Politoff, A., Macri, F.: Pharmacologic differences between isolated, perfused arteries of the choroid plexus and of the brain parenchyma. Int. J. Neuropharmacol. 5, 155–162 (1966)
Poulson, E., Robson, J.M.: Prevention by antagonists of the toxic action of 5-hydroxytryptamine on pregnancy. Brit. J. Pharmacol. 21, 150–154 (1963)
Pourrias, B.: Analyse des effets tensionels et cardiaques de la tryptine. J. Pharmacol. (Paris) 6, 153–164 (1975)
Prince, W.T., Berridge, J., Rasmussen, H.: Role of calcium and adenosine-3′,5′-cyclic monophosphate in controlling fly salivary gland secretion. Proc. natl. Acad. Sci. (Wash.) 69, 553–557 (1972)
Proudfit, K., Anderson, E.G.: Alteration by serotonin antagonists of the effects of bulbospinal stimulation on spinal reflex pathways. Fed. Proc. 31, 270 (1972)
Proudfit, H.K., Anderson, E.G.: Influence of serotonin antagonists on bulbospinal systems. Brain Res. 61, 331–341 (1973)
Przewlocki, R.: The effect of serotonin microinjections into the nuclei amygdale on EEG and behaviour in the rabbit. Pol. J. Pharmacol. Pharm. 27 (Suppl.), 209–216 (1975)
Rand, M.J., McCulloch, M.W., Story, D.F.: Pre-junctional modulation of noradrenergic transmission by noradrenaline, dopamine and acetylcholine. In: Central Action of Drugs in Blood Pressure Regulation. Davies, D.S., Reid, J.L. (eds.), pp. 94–132. Kent: Pitman Medical Publishing 1975
Randic, M., Padjen, A.: Effect of N,N-dimethyltryptamine and D-lysergic acid diethylamide on the release of 5-hydroxy-indoles in rat forebrain. Nature (Lond.) 230, 532–533 (1971)
Rao, K.R., Fingerman, M.: Action of biogenic amines on crustacean chromatophores. II. Analysis of the responses of erythrophores in the fiddler crab, Uca pugilator, to indolealkylamines and an eyestalk hormone. Comp. gen. Pharmacol. 1, 117–126 (1970)
Regoli, D., Vane, J.R.: A sensitive method for the assay of angiotensin. Brit. J. Pharmacol. 23, 351–359 (1964)
Reichenberg, K., Wiszniowska, G., Marchaj, J.: The influence of 5-hydroxytryptophan (5-HTP) administered into the lateral brain ventricle on the behavior and body temperature in rats. Pol. J. Pharmacol. Pharm. 27 (Suppl.), 217–222 (1975)
Rico, J.M.G.T., Rico, J.T., Ferreira, J.M.C., Cravo, A.C.: L’effet des prostaglandines PGE1, PGE2 et PGF2α sur la perméabilité vasculaire chez le rat. C.R. Soc. Biol. (Paris) 167, 1315–1318 (1973)
Roberts, M.H., Straughan, D.W.: Excitation and depression of cortical neurones by 5-hydroxytryptamine. J. Physiol. (Lond.) 193, 269–294 (1967)
Rocha e Silva, M., Valle, J.R., Picarelli, Z.P.: A pharmacological analysis of the mode of action of serotonin (5-hydroxytryptamine) upon the guinea-pig ileum. Brit. J. Pharmacol. 8, 378–388 (1953)
Rossler, R., Unna, K.: Zur Pharmakologie des neuen Mutterkornalkaloides Sensibamin. Naunyn-Schmiedebergs Arch. Pharmacol. 179, 115–126 (1935)
Rose, J.C., Lazaro, E.J.: Pulmonary vascular responses to serotonin and effects of certain serotonin antagonists. Circulat. Res. 6, 283–288 (1958)
Rosecrans, J.A., Lovell, R.A., Freedman, D.X.: Effects of lysergic acid diethylamide on the metabolism of brain 5-hydroxytryptamine. Biochem. Pharmacol. 16, 2011–2021 (1967)
Rosenblueth, A.: The action of certain drugs on the nictitating membrane. Amer. J. Physiol. 100, 443–446 (1932)
Ross, S.B., Renyi, A.L.: Accumulation of tritiated 5-hydroxytryptamine in brain slices. Life Sci. 6, 1407–1415 (1967)
Roth, J.: Peptide hormone binding to receptors: a review of direct studies in vitro. Metabolism 22, 1059–1073 (1973)
Rothlin, E.: Über die pharmakologische und therapeutische Wirkung des Ergotamins auf den Sympathicus. Klin. Wschr. 4, 1437–1443 (1925)
Rothlin, E.: Zur Pharmakologie des Sympathicolyticums Dihydroergotamin DHE 45. Schweiz. med. Wschr. 76, 1254–1259 (1946)
Rothlin, E.: The pharmacology of the natural and dihydrogenated alkaloids of ergot. Bull. schweiz. Akad. med. Wiss. 2, 249–273 (1946/47)
Rothlin, E.: Pharmacology of lysergic acid diethylamide (LSD) and some of its related compounds. In: Psychotropic drugs. Garattini, S., Ghetti, V. (eds.), pp. 36–47. Amsterdam: Elsevier Press 1957a
Rothlin, E.: Lysergic acid diethylamide and related substances. Ann. N.Y. Acad. Sci. 66, 668–676 (1957b)
Rothlin, E.: Pharmacology of lysergic acid diethylamide and some of its related compounds. J. Pharm. Pharmacol. 9, 569–587 (1957c)
Rothlin, E., Berde, B.: Über die Wirkung hydrierter Mutterkornalkaloide auf isolierte Muskelstreifen des menschlichen Uterus nahe am Termin, am Termin und während der Geburt. Helv. physiol. pharmacol. Acta 12, 191–205 (1954)
Rothlin, E., Brügger, J.: Quantitative Differenzierung von 4 genuinen und hydrierten Mutterkornalkaloiden am isolierten Kaninchen-Uterus und an der isolierten Samenblase des Meerschweinchens. Helv. physiol. pharmacol. Acta 3, C43–C44 (1945a)
Rothlin, E., Brügger, J.: Quantitative Untersuchungen der sympathikolytischen Wirkung genuiner Mutterkornalkaloide und derer Dihydroderivate am isolierten Uterus des Kaninchens. Helv. physiol. pharmacol. Acta 3, 519–535 (1945b)
Rothlin, E., Cerletti, A.: Pharmakologie des Hochdrucks. Verh. dtsch. Ges. Kreisl.-Forsch. 15, 158–185 (1949)
Rothlin, E., Konzett, H., Cerletti, A.: The antagonism of ergot alkaloids towards the inhibitory response of the isolated rabbit intestine to epinephrine and norepinephrine. J. Pharmacol. exp. Ther. 112, 185–190 (1954)
Rózsa, K.S., Graul, C.: Is serotonin responsible for the stimulative effect of the extracardiac nerve in Helix pomatia? Ann. Biol. Tihany 31, 85–96 (1964)
Ruch-Monachon, M.-A., Jalfre, M., Haefely, W.: Drugs and PGO waves in the lateral geniculate body of the curarized cat. II. PGO wave activity and brain 5-hydroxytryptamine. Arch. int. Pharmacodyn. 219, 269–286 (1976a)
Ruch-Monachon, M.-A., Jalfre, M., Haefely, W.: Drugs and PGO waves in the lateral geniculate body of the curarized cat. V. Miscellaneous compounds. Synopsis of the role of central neurotransmitters on PGO wave activity. Arch. int. Pharmacodyn. 219, 326–346 (1976b)
Ruckebusch, Y., Roche, M., Schurch, D.: Parallelisms des effets des psychodysleptiques majeure sur la toxicité de groupe et de taux cérébral en sérotonine. C.R. Soc. Biol. (Paris) 159, 1745–1748 (1965)
Rudzik, A.D., Miller, J.W.: The mechanism of uterine inhibitory action of relaxin-containing ovarian extracts. J. Pharmacol. exp. Ther. 138, 82–87 (1962)
Saad, K.: The effect of drugs on the isolated splenic capsule of man and other animals. Quart. J. Pharm. Pharmacol. 8, 31–38 (1935)
Sachs, E., Yonkman, F.F.: The pharmacological behavior of the intraocular muscles. V. The action of yohimbine and ergotamine on the dilator iridis. J. Pharmacol. exp. Ther. 75, 105–110 (1942)
Salmoiraghi, G.C., McCubbin, J.W., Page, I.H.: Effects of D-lysergic acid diethylamide and its brom derivative on cardiovascular responses to serotonin and on arterial pressure. J. Pharmacol. exp. Ther. 119, 240–247 (1957)
Salmoiraghi, G.C., Bloom, F.E., Costa, E.: Adrenergic mechanisms in rabbit olfactory bulb. Amer. J. Physiol. 207, 1417–1424 (1964)
Salzmann, R., Kalberer, F.: Antimigraine drugs and storage of serotonin. In: Background to Migraine. Cumings, J.N. (ed.), pp. 63–72. London: William Heinemann Medical Books 1973
Salzmann, R., Pacha, W.: Vergleichende Untersuchungen über die Beeinflussung adrenerger Reaktionen durch Ergotamin und Dihydroergotamin an verschiedenen Versuchsmodellen. Helv. physiol. pharmacol. Acta 26, CR246–CR248 (1968)
Salzmann, R., Pacha, W.: The effects of ergot compounds on the release of noradrenaline and prostaglandins from the isolated perfused cat spleen during nerve stimulation. Postgrad. med. J. 52 (Suppl. 1), 24–31 (1976)
Salzmann, R., Weidmann, H.: Die Wirkung von Ergotamin auf humorale und neuronale Effekte an der Nickhaut der Katze. Helv. physiol. pharmacol. Acta 24, C117 (1966)
Salzmann, R., Pacha, W., Weidmann, H.: Der Einfluß von Ergotamin auf humorale und neuronale Wirkungen an der Nickhaut und an der Milz der Katze. Helv. physiol. pharmacol. Acta 25, CR433–CR435 (1967)
Salzmann, R., Pacha, W., Taeschler, M., Weidmann, H.: The effect of ergotamine on humoral and neuronal actions in the nictitating membrane and the spleen of the cat. Naunyn-Schmiedebergs Arch. Pharmacol. 261, 360–378 (1968)
Sankar, D.V.S., Sankar, D.B., Phipps, E., Gold, E.: Effect of administration of lysergic acid diethylamide on serotonin levels in the body. Nature (Lond.) 191, 499–500 (1961)
Sankar, D.V.S., Phipps, E., Gold, E., Sankar, D.B.: Effect of LSD, BOL, and chlorpromazine on “Neurohormone” metabolism. Ann. N.Y. Acad. Sci. 96, 93–97 (1962)
Sankar, D.V.S., Broer, H.H., Cates, N., Sankar, D.B.: Studies on biogenic amines and psychoactive drug actions, with special reference to lysergic acid diethyl amide. Trans. N.Y. Acad. Sci. 26, 369–379 (1964)
Sankar, D.V.S., Cates, N.R., Domjan, M.: Comparative biochemical pharmacology of psychoactive drugs. Clin. Res. 17, 395 (1969)
Sato, M., Sawada, M.: Selective blocking action of LSD on inhibitory dopamine receptors. Neuropharmacology 14, 883–886 (1975)
Savini, E.C.: The antagonism between 5-hydroxytryptamine and certain derivatives of lysergic acid. Brit. J. Pharmacol. 11, 313–317 (1956)
Saxena, P.R.: The effects of antimigraine drugs on the vascular responses by 5-hydroxytryptamine and related biogenic substances on the external carotid bed of dogs: possible pharmacological implications to their antimigraine action. Headache 12, 44–45 (1972a)
Saxena, P.R.: The effects of some antimigraine drugs on the vascular resistance in the external carotid bed of the dog. In: Vascular Smooth Muscle. Betz, E. (ed.), pp. 93–95. Berlin-Heidelberg-New York: Springer 1972b
Saxena, P.R.: Selective carotid vasoconstriction by ergotamine as a relevant mechanism in its antimigraine action. Arch. Neurobiol. 37 (Suppl.), 301–315 (1974a)
Saxena, P.R.: Selective vasoconstriction in carotid vascular bed by methysergide: possible relevance to its antimigraine effect. Europ. J. Pharmacol. 27, 99–105 (1974b)
Saxena, P.R.: On the mechanism of action of methysergide in vascular headaches of migraine type. In: Headache, II. Biochemical Bases and Drug Therapy. Munch. Med. Wochenschr. (ed.), pp. 91–100, 137–138. München: O. Spatz 1975
Saxena, P.R., De Vlaam-Schluter, G.M.: Role of some biogenic substances in migraine and relevant mechanism in antimigraine action of ergotamine-studies in an experimental model for migraine. Headache 13, 142–163 (1974)
Saxena, P.R., van Houwelingen, P., Bonta, I.L.: The effects of mianserin hydrochloride on the vascular responses evoked by 5-hydroxytryptamine and related vasoactive substances. Europ. J. Pharmacol. 13, 295–305 (1971)
Schanberg, S.M., Giarman, N.J.: Uptake of serotonin (5-HT) and 5-hydroxytryptophan (5-HTP) by brain slices. Pharmacologist 2, 67 (1960)
Schanberg, S.M., Giarman, N.J.: Drug-induced alterations in the sub-cellular distribution of 5-hydroxytryptamine in rat’s brain. Biochem. Pharmacol. 11, 187–194 (1962)
Scherbel, A.: Pharmacodynamic effects of UML-491 in animal and man. Wiss. Ausstellung, 6. Int. Kongress Inn. Med., Basel, August 1960, Abstract
Schild, H.O.: pA, a new scale for the measurement of drug antagonism. Brit. J. Pharmacol. 2, 189–206 (1947)
Schild, H.O.: Non-competitive antagonism. J. Physiol. (Lond.) 124, 33P–34P (1954)
Schild, H.O.: Effect of adrenaline on depolarized smooth muscle. In: Ciba Foundation Symposium on Adrenergic Mechanisms. Wolstenholme, G.E.W., O’Connor, M. (eds.), pp. 288–294. London: J. and A. Churchill 1960
Schild, H.O.: Parallelism of log dose-response curves in competitive antagonism. Pharmacol. Res. Commun. 1, 1–2 (1969)
Schild, H.O.: Some aspects of receptor pharmacology of ergotamine. Postgrad. med. J. 52 (Suppl. 1), 9–11 (1976)
Schildkraut, J.J., Schanberg, S.M., Breese, G.R., Kopin, I.J.: Effects of psychoactive drugs on the metabolism of intracisternally administered serotonin in rat brain. Biochem. Pharmacol. 18, 1971–1978 (1969)
Schlientz, W., Brunner, R., Rüegger, A., Berde, B., Stürmer, E., Hofmann, A.: β-Ergokryptin, ein neues Alkaloid der Ergotoxin-Gruppe. Pharm. Acta Helv. 43, 497–509 (1968)
Schönbaum, E., Lamar, J.-C.: Anti-serotonin drugs in nasal vessels. Sixth Internat. Congress Pharmacology, Helsinki, 1975, Abstract 698
Schönbaum, E., Vargaftig, B.B., Lefort, J.: Nasal vessels and serotonin. Pharmacologist 16, 243 (1974)
Schönbaum, E., Vargaftig, B.B., Lefort, J., Lamar, J.C., Hasenack, T.: An unexpected effect of serotonin antagonists on the canine nasal circulation. Headache 15, 180–187 (1975)
Scholtysik, G.: Inhibition of accelerator nerve stimulation in cats by dihydroergotoxine. Sixth Internat. Congress Pharmacology, Helsinki, 1975, Abstract 742
Schorderet, M.: Direct evidence for the stimulation of rabbit retina dopamine receptors by ergot alkaloids. Neurosci. Lett. 2, 87–91 (1976)
Schorderet, M., Frangaki, A.: Effects of antiparkinsonian drugs on cAMP accumulation in rabbit retina. Experientia (Basel) 32, 782 (1976)
Schubert, J., Nybäck, H., Sedvall, G.: Accumulation and disappearance of 3H-5-hydroxytryptamine formed from 3H-tryptophan in mouse brain: effect of LSD 25. Europ. J. Pharmacol. 10, 215–224 (1970)
Schwarz, B.E., Wakim, K.G., Bickford, R.G., Lichtenheld, F.R.: Behavioural and electroencephalographic effects of hallucinogenic drugs. Arch. Neurol. Psychiat. (Chic.) 75, 83–90 (1956)
Scriabine, A., Bellet, S., Kershbaum, A., Feinberg, L.J.: Effect of dihydroergotamine on plasma free fatty acids (FFA) in dogs. Life Sci. 7, 453–463 (1968)
Segal, M.: Physiological and pharmacological evidence for a serotonergic projection to the hippocampus. Brain Res. 94, 115–131 (1975)
Segal, M., Bloom, F.E.: The projection of midline raphe nuclei to the hippocampus of the rat. Fed. Proc. 33, 299 (1974)
Seiler, K.-U., Wassermann, O.: MAO-inhibitory properties of anorectic drugs. J. Pharm. Pharmacol. 25, 576–578 (1973)
Shaskan, E.G., Snyder, S.H.: Kinetics of serotonin accumulation into slices from rat brain: relationship to catecholamine uptake. J. Pharm. exp. Ther. 175, 404–418 (1970)
Shaw, E., Woolley, D.W.: Yohimbine and ergot alkaloids as naturally occurring antimetabolites of serotonin. J. biol. Chem. 203, 978–989 (1953)
Shaw, E., Woolley, D.W.: Some serotoninlike activities of lysergic acid diethylamide. Science 124, 121–122 (1956)
Shibuya, T., Anderson, E.G.: The influence of chronic cord transection on the effects of 5-hydroxytryptophan, L-tryptophan and pargyline on spinal neuronal activity. J. Pharmacol. exp. Ther. 164, 185–190 (1968)
Shields, P.J., Eccleston, D.: Evidence for the synthesis and storage of 5-hydroxytryptamine in two separate pools in the brain. J. Neurochem. 20, 881–888 (1973)
Shimahara, T., Tauc, L.: Heterosynaptic facilitation in the giant cell of Aplysia. J. Physiol. (Lond.) 247, 321–342 (1975)
Sicuteri, F., Michelacci, S., Franchi, G.: Antagonism between an antiserotonin-the butanolamide of 1-methyl-lysergic acid-and the effects of a histamine-liberating substance 48/80 B.W. in man. Int. Arch. Allergy 15, 291–299 (1959)
Sicuteri, F., Franchi, G., Michelacci, S.: Inhibition by lysergic acid derivatives of bronchospasm induced in guinea-pigs by serotonin aerosol. Med. Exp. 3, 89–94 (1960)
Sicuteri, F., Del Bianco, P.L., Fanciullacci, M., Franchi, G.: II test della venocostrizione per la misura della sensibilita alia 5-idossitriptamina e alle catecolamine nell’uomo. Boll. Soc. ital. Biol. sper. 40, 1148–1150 (1964a)
Sicuteri, F., Fanciullacci, M., Del Bianco, P.L., Franchi, G.: Inibizione della venocostrizione da 5-idrossitriptamina nell’uomo da parte del metisergide (UML-491) e di altri antiserotoninici. Boll. Soc. ital. Biol. sper. 40, 1151–1152 (1964b)
Sicuteri, F., Franchi, G., Fanciullacci, M.: Serotonin potentiation of methysergide, LSD 25 and ergotamine in man: An informal approach to migraine pharmacology. In: Headache, II. Biochemical Bases and Drug Therapy. Munch. Med. Wochenschr. (ed.), pp. 101–104, 137–138. München: O. Spatz 1975
Simon, G., Winter, M.: The effect of sympatholytic and sympathomimetic agents on acetylcholinesterase and cholinesterase activity in vitro. Biochem. Pharmacol. 25, 881–882 (1976)
Slater, I.H., Davis, K.H., Leary, D.E., Boyd, E.S.: The action of serotonin and lysergic acid diethylamide on spinal reflexes. J. Pharmacol. exp. Ther. 113, 48–49 (1955)
Smith, C.B.: Relaxation of the nictitating membrane of the spinal cat by sympathomimetic amines. J. Pharmacol. exp. Ther. 142, 163–170 (1963)
Snider, S.R., Hutt, C., Stein, B., Fahn, S.: Increase in brain serotonin produced by bromocryptine. Neurosci. Lett. 1, 237–241 (1975)
Snider, S.R., Hutt, C., Stein, B., Prasad, A.L.N., Fahn, S.: Correlation of behavioural inhibition or excitation produced by bromocriptine with changes in brain catecholamine turnover. J. Pharm. Pharmacol. 28, 563–566 (1976)
Snyder, S.H., Bennett, J.P.: Neurotransmitter receptors in the brain: biochemical identification. Annu. Rev. Physiol. 38, 153–175 (1976)
Sofia, R.D., Vassar, H.B.: The effects of ergotamine and methysergide on serotonin metabolism in the rat brain. Arch. int. Pharmacodyn. 216, 40–50 (1975)
Sollero, L., Page, I.H., Salmoiraghi, G.C.: Brom-lysergic acid diethylamide: A highly potent serotonin antagonist. J. Pharmacol. exp. Ther. 117, 10–15 (1956)
Sollmann, T.: A Manual of Pharmacology and its Applications to Therapeutics and Toxicology, 7th ed. Philadelphia-London: W.B. Saunders 1948
Sollmann, T., Brown, E.D.: Intravenous injection of ergot. J. Amer. med. Ass. 45, 229–240 (1905)
Sonneville, P.F.: An indirect action of dopamine on the rat fundus strip mediated by 5-hydroxytryptamine. Europ. J. Pharmacol. 2, 367–370 (1968)
Spano, P.F., Cattabeni, F., Govoni, S., Trabucchi, M.: Selective stimulation by d-LSD of dopamine-sensitive adenylate cyclase in various rat brain areas. Sixth Internat. Congress Pharmacol., Helsinki, 1975a, Abstract 186
Spano, P.F., Kumakura, K., Tonon, G.C., Govoni, S., Trabucchi, M.: LSD and dopaminesensitive adenylate cyclase in various rat brain areas. Brain Res. 93, 164–167 (1975b)
Sparber, S.B.: Neurochemical changes associated with schedule controlled behavior. Fed. Proc. 34, 1802–1812 (1975)
Stacey, R.S.: Uptake of 5-hydroxytryptamine by platelets. Brit. J. Pharmacol. 16, 284–295 (1961)
Stadler, P.A., Stürmer, E.: Comparative studies on the pharmacological properties of stereoisomers of ergotamine and dihydroergotamine. Naunyn-Schmiedebergs Arch. Pharmacol. 266, 457–458 (1970)
Starke, K.: α-Sympathomimetic inhibition of adrenergic and cholinergic transmission in the rabbit heart. Naunyn-Schmiedebergs Arch. Pharmacol. 274, 18–45 (1972)
Starke, K., Montel, H.: Sympathomimetic inhibition of noradrenaline release: mediated by prostaglandins? Naunyn-Schmiedebergs Arch. Pharmacol. 278, 111–116 (1973)
Starr, M.S., West, G.B.: The effect of bradykinin and anti-inflammatory agents on isolated arteries. J. Pharm. Pharmacol. 18, 838–840 (1966)
Stephenson, R.P.: A modification of receptor theory. Brit. J. Pharmacol. 11, 379–393 (1956)
Stevens, B., Baguet, F.: Action de l’acide bromolysergique diethylamide (BOL 148) sur les propriétés mécaniques d’un muscle lisse de Lamellibranche. Arch. int. Physiol. Biochim. 76, 552–554 (1968)
Stjärne, L., Lishajko, F.: Drug-induced inhibition of noradrenaline synthesis in vitro in bovine splenic nerve tissue. Brit. J. Pharmacol. 27, 398–404 (1966)
Stjärne, L., Wennmalm, A.: Quantitative estimation of secretion and reuptake of adrenergic transmitter in the rabbit heart. Acta physiol. scand. 81, 286–288 (1971)
Stolk, J.M., Barchas, J.D., Goldstein, M., Boggan, W., Freedman, D.X.: A comparison of psychotomimetic drug effects on rat brain norepinephrine metabolism. J. Pharmacol. exp. Ther. 189, 42–50 (1974)
Stoll, A., Hofmann, A.: The ergot alkaloids. In: The Alkaloids. Manske, R.H.F. (ed.), Chap. 21, Vol. VIII. New York: Academic Press 1965
Stone, C.A., Wenger, H.C., Ludden, C.T., Stavorski, J.M., Ross, C.A.: Antiserotonin-antihistaminic properties of cyproheptadine. J. Pharmacol. exp. Ther. 131, 73–84 (1961)
Stone, T.W.: Further evidence for a dopamine receptor stimulating action of an ergot alkaloid. Brain Res. 72, 177–180 (1974)
Straczowski, W., Kalicinski, A., Nowak, W., Malofiejew, M.: The effects of prostaglandin A2 (PGA2) on the guinea-pig isolated ileum. Pol. J. Pharmacol. Pharm. 26, 253–255 (1974)
Strandhoy, J.W., Cronnelly, R., Long, J.P., Williamson, H.E.: Effects of vasoactive agents and diuretics on isolated superfused interlobar renal arteries. Proc. Soc. exp. Biol. (N.Y.) 141, 336–339 (1972)
Streuli, H.: Die Wechselwirkung von inneren Sekreten und die Beziehung dieser Wirkung zum Problem der Erregung und Hemmung. Z. Biol. 66, 167–228 (1916)
Strong, C.G., Bohr, D.F.: Effects of Prostaglandins E1, E2, A1 and F1α on isolated vascular smooth muscle. Circulation 36 (Suppl. 2), II 244–11 245 (1967a)
Strong, C.G., Bohr, D.F.: Effects of prostaglandins E1, E2, A1 and F1α on isolated vascular smooth muscle. Amer. J. Physiol. 213, 725–733 (1967b)
Struyker Boudier, H., Van Rossum, J.M.: Dopamine-induced inhibition and excitation of neurones of the snail Helix aspersa. Arch. int. Pharmacodyn. 209, 314–324 (1974)
Struyker Boudier, H.A.J., Gielen, W., Cools, A.R., Van Rossum, J.M.: Pharmacological analysis of dopamine-induced inhibition and excitation of neurones of the snail Helix aspersa. Arch. int. Pharmacodyn. 209, 324–331 (1974)
Struyker Boudier, H., Teppema, L., Cools, A., Van Rossum, J.M.: (3,4-dihydroxy-phenylamino)-2-imidazoline (DPI), a new potent agonist at dopamine receptors mediating neuronal inhibition. J. Pharm. Pharmacol. 27, 882–883 (1975)
Sugrue, M.F.: A study of the role of noradrenaline in behavioural changes produced in the rat by psychotomimetic drugs. Brit. J. Pharmacol. 35, 243–252 (1969)
Svensson, T.H., Bunney, B.S., Aghajanian, G.K.: Noradrenergic regulation of brain serotonergic neurons: Evidence from single unit studies with clonidine. Pharmacologist 16, 244 (1974)
Swank, R.L., Fellman, J.H.: Blood cell aggregation and biological agents. Bibl. anat. (Basel) 8–9, 98–103 (1966)
Swank, R.L., Fellman, J.H., Hissen, W.W.: Aggregation of blood cells by 5-hydroxytryptamine (serotonin). Circulat. Res. 13, 392–400 (1963)
Szabadi, E., Bradshaw, C.M.: The role of physical and biological factors in determining the time course of neuronal responses. Neuropharmacology 13, 537–545 (1974)
Szara, S., Morton, D.M., Aikens, A.: Comparison of hallucinogenic and nonhallucinogenic congeners on regional serotonin metabolism in brain. Pharmacologist 9, 250 (1967)
Takeuchi, H., Mori, A., Kohsaka, M.: Effets des indolamines et de leurs analogues sur l’activité électrique d’un neurone géant identifié d’Achatina fulica Ferussac. C.R. Soc. Biol. (Paris) 186, 658–663 (1974)
Tardos, L., Adam, V.: The chronotropic activity of serotonin. Naunyn-Schmiedebergs Arch. Pharmacol. 248 (Suppl.), R81 (1974)
Tebécis, A.K., DiMaria, A.: A re-evaluation of the mode of action of 5-hydroxytryptamine on lateral geniculate neurones: Comparison with catecholamines and LSD. Exp. Brain Res. 14, 480–493 (1972)
Teraki, Y.: A study on the action mechanism of foetal death with 5-HT and the influence of its antagonists. Acta obstet. gynaec. Jap. 17, 142 (1970)
Thierry, A.M., Blanc, G., Sobel, A., Stinus, L., Glowinski, J.: Dopaminergic terminals in rat cortex. Science 182, 499–501 (1973a)
Thierry, A.M., Stinus, L., Blanc, G., Glowinski, J.: Some evidence for the existence of dopaminergic neurones in the rat cortex. Brain Res. 50, 230–234 (1973b)
Thoenen, H., Hürlimann, A., Haefely, W.: Dual site of action of phenoxybenzamine in the cat’s spleen: Blockade of α-adrenergic receptors and inhibition of re-uptake of neurally released norepinephrine. Experientia (Basel) 20, 272–273 (1964a)
Thoenen, H., Hürlimann, A., Haefely, W.: Wirkungen von Phenoxybenzamin, Phentolamin und Azapetin auf adrenergische Synapsen der Katzenmilz. Helv. physiol. pharmacol. Acta 22, 148–161 (1964b)
Thompson, J.H., Campbell, L.B.: The influence of 1-methyl-d-lysergic acid butanolamide on gastrointestinal serotonin in the Sprague-Dawley rat. Biochem. Pharmacol. 16, 1377–1380 (1967)
Thompson, J.W.: Studies on the responses of the isolated nictitating membrane of the cat. J. Physiol. (Lond.) 141, 46–72 (1958)
Thompson, M.R.: Some properties of ergostetrine. J. Amer. Pharm. Ass. 24, 748–753 (1935)
Thompson, R.H.S., Tickner, A., Webster, G.R.: Cholinesterase inhibition by lysergic acid diethylamide. Biochem. J. 58, XIX–XX (1954)
Thompson, R.H.S., Tickner, A., Webster, G.R.: The action of lysergic acid diethylamide on mammalian cholinesterases. Brit. J. Pharmacol. 10, 61–65 (1955)
Thulin, A.: Motor and secretory effects of autonomic nerves and drugs in the rat submaxillary gland. Acta physiol. scand. 92, 217–223 (1974)
Thulin, A.: Influence of autonomic nerves and drugs on myoepithelial cells in parotid gland of cat. Acta physiol. scand. 93, 477–482 (1975)
Tilson, H.A., Sparber, S.B.: Studies on the concurrent behavioral and neurochemical effects of psychoactive drugs using the push-pull cannula. J. Pharmacol. exp. Ther. 181, 387–398 (1972)
Toda, N.: Influence of 5-hydroxykynurenamine, a new serotonin metabolite, on isolated cerebral arteries. Jap. J. Pharmacol. 24 (Suppl.), 68 (1974)
Toda, N.: Analysis of the effect of 5-hydroxykynurenamine, a serotonin metabolite, on isolated cerebral arteries, aortas and atria. J. Pharmacol. exp. Ther. 193, 385–392 (1975)
Toda, N., Goldberg, L.I.: Dopamine-induced relaxation of isolated arterial strips. J. Pharm. Pharmacol. 25, 587–589 (1973)
Toda, N., Goldberg, L.I.: Effects of dopamine on isolated canine coronary arteries. Cardiovasc. Res. 9, 384–389 (1975)
Toda, N., Goldberg, L.I., Fujiwara, M.: Dopamine-induced relaxation of isolated blood vessels. Jap. J. Pharmacol. 23 (Suppl.), 45 (1973)
Toda, N., Tokuyama, T., Senoh, S., Hirata, F., Hayaishi, O.: Effects of 5-hydroxykynurenamine, a new serotonin metabolite, on isolated dog basilar arteries. Proc. natl. Acad. Sci. (Wash.) 71, 122–124 (1974)
Toda, N., Hayashi, S., Fu, W.L.H., Nagasaka, Y.: Serotonin antagonism in isolated canine cerebral arteries. Jap. J. Pharmacol. 26, 57–63 (1976)
Tomosky, T.K., Bennett, J.L., Bueding, E.: Tryptaminergic and dopaminergic responses of Schistosoma mansoni. J. Pharmacol. exp. Ther. 190, 260–271 (1974)
Tonge, S.R., Leonard, B.E.: The effects of some hallucinogenic drugs upon the metabolism of 5-hydroxy-tryptamine in the brain. Life Sci. 8 (I), 805–814 (1969)
Tonge, S.R., Leonard, B.E.: The effect of some hallucinogenic drugs on the amino acid precursors of brain monoamines. Life Sci. 9 (I), 1327–1335 (1970)
Torre, M., Bogetto, F., Torre, E.: Effect of LSD-25 and 1-methyl-d-lysergic acid butanolamide on rat brain and platelet serotonin levels. Psychopharmacologia 36, 117–122 (1974a)
Torre, M., Torre, E., Bogetto, F.: Somministrazione di etanolo a varie dosi: livelli di serotonina cerebrale nel ratto. Somministrazione contemporanea di LSD-25 e UML: Livelli di serotonina cerebrale e comportamento condizionato nel ratto. Boll. Soc. ital. Biol. sper. 50, 1639–1645 (1974b)
Tothill, A.: Investigation of adrenaline reversal in the rat uterus by the induction of resistance to isoprenaline. Brit. J. Pharmacol. 29, 291–301 (1967)
Trabucchi, M., Spano, P.F., Tonon, G.C., Frattola, L.: Effects of bromocriptine on central dopaminergic receptors. Life Sci. 19, 225–232 (1976)
Trenchard, A., Turner, P., Pare, C.M.B., Hills, M.: The effects of protryptiline and clomipramine in vitro on the uptake of 5-hydroxytryptamine and dopamine in human platelet-rich plasma. Psychopharmacologia 43, 89–93 (1975)
Trendelenburg, U.: The action of histamine and 5-hydroxytryptamine on isolated mammalian atria. J. Pharmacol. exp. Ther. 130, 450–460 (1960)
Türker, K., Kiran, B.K., Kaymakcalan, S.: Distribution of adrenergic receptors in the cat ileum. Arch. int. Pharmacodyn. 156, 130–142 (1965)
Türker, R.K., Khairallah, P.A.: Prostaglandin E1 action on canine isolated tracheal muscle. J. Pharm. Pharmacol. 21, 498–501 (1969)
Tuomisto, J.: Inhibition of noradrenaline (NA), dopamine (DA) and 5-HT uptake in synaptosomes by reserpine, 6-hydroxy-1,2,3,4-tetrahydroharmane (6HTH), LSD and ergotamine. J. Pharmacol. (Paris) 5 (Suppl. 2), 100 (1974)
Turner, P.: Some pharmacological studies on drugs used in the prophylactic treatment of migraine. In: Background to Migraine. Cumings, J.N. (ed.), pp. 170–173. London: William Heinemann Medical Books 1973
Twarog, B.M.: Responses of a molluscan smooth muscle to acetylcholine and 5-hydroxytryptamine. J. cell. comp. Physiol. 44, 141–164 (1954)
Ungar, F., Hitri, A., Alivisatos, S.G.A.: Drug antagonism and reversibility of the binding of indole amines in brain. Europ. J. Pharmacol. 36, 115–125 (1976)
Urquilla, P.R., Marco, E., Lluch, S.: Pharmacological receptors of the cerebral blood vessels of the goat. Fed. Proc. 33, 568 (1974)
Urquilla, P.R., Marco, E.J., Lluch, S.: Pharmacological receptors of the cerebral arteries of the goat. Blood Vessels 12, 53–67 (1975)
Uzunov, P., Weiss, B.: Psychopharmacological agents and the cyclic AMP system of rat brain. Adv. Cyclic Nucleotide Res. 1, 435–451 (1972)
Valdecasas, F.G., Calvet, F., Cuenca, E., Salva, J.A.: Die potenzierende Wirkung verschiedener psychoaktiver Substanzen auf Adrenalin und Serotonin. Arzneimittel-Forsch. 6, 594–596 (1956)
Vane, J.R.: A sensitive method for the assay of 5-hydroxytryptamine. Brit. J. Pharmacol. 12, 344–349 (1957)
Vane, J.R.: The actions of sympathomimetic amines on tryptamine receptors. In: Ciba Foundation Symposium on Adrenergic Mechanisms, pp. 356–372. London: J. and A. Churchill 1960
Van Rossum, J.M.: Cumulative dose-response curves. II. Technique for the making of doseresponse curves in isolated organs and the evaluation of drug parameters. Arch. int. Pharmacodyn. 143, 299–330 (1963)
Van Rossum, J.M., Pijnenburg, A.J.J., Cools, A.R., Broekkamp, C.L.E., Struyker Boudier, H.A.J.: Behavioural pharmacology of the neostriatum and the limbic striatum. In: Neuropharmacology. Excerpta Medica Int. Congress Series No. 359, pp. 505–516. Amsterdam 1975
Vargaftig, B.B., Lefort, J.: Pharmacological evidence for a vasodilator receptor to serotonin in the nasal vessels of the dog. Europ. J. Pharmacol. 25, 216–225 (1974)
Vidrio, H., Hong, E.: Vascular tone and reactivity to serotonin in the internal and external carotid vascular beds of the dog. J. Pharmacol. exp. Ther. 197, 49–56 (1976)
Vogel, G., Marek, M.L.: Über die Hemmung verschiedener Rattenpfoten-Oedeme durch Serotonin-Antagonisten. Arzneimittel-Forsch. 11, 1051–1054 (1961)
Vogt, M.: Drugs interfering with central actions of 5-hydroxytryptamine. In: Ciba Foundation Symposium on Hypertension, pp. 209–213. London: J. and A. Churchill 1954
Vogt, M., Gunn, C.G., Sawyer, Ch.: Electroencephalographic effects of intraventricular 5-HT and LSD in the cat. Neurology (Minneap.) 7, 559–566 (1957)
Von Hungen, K., Roberts, S., Hill, D.F.: Serotonin and catecholamine activation of brain adenylate cyclase: Effects of psychoactive drugs. Trans. Amer. Soc. Neurochem. 5, 150 (1974a)
Von Hungen, K., Roberts, S., Hill, D.F.: LSD as an antagonist at central dopamine receptors. Nature (Lond.) 252, 588–589 (1974b)
Von Hungen, K., Roberts, S., Hill, D.F.: Serotonin-sensitive adenylate cyclase activity in immature rat brain. Brain Res. 84, 257–267 (1975)
Votava, Z., Lamplová, I.: Antiserotonin effect of derivatives of d-lysergic acid (cycloalkylamides, LSD, ergometrine) and chlorpromazine in rats. Activ. nerv. sup. (Praha) 1, 269–275 (1959)
Votava, Z., Podvalová, I., Semonský, M.: Oxytocic effect of some d-lysergic acid cycloalkylamides. Nature (Lond.) 179, 474–475 (1957)
Votava, Z., Podvalová, I., Semonský, M.: Studies on the pharmacology of d-lysergic acid cycloalkylamides. Arch. int. Pharmacodyn. 115, 114–130 (1958)
Walker, R.J., Woodruff, G.N., Glaizner, B., Sedden, C.B., Kerkut, G.A.: The pharmacology of Helix dopamine receptor of specific neurones in the snail, Helix aspersa. Comp. Biochem. Physiol. 24, 455–469 (1968)
Walsh, J.A.: Antagonism by methysergide of vascular effects of 5-hydroxytryptamine in man. Brit. J. Pharmacol. 30, 518–530 (1967)
Walters, J.R., Roth, R.H., Aghajanian, G.K.: Dopaminergic neurons, similar biochemical and histochemical effects of γ-hydroxybutyrate and acute lesions of the nigro-striatal pathway. J. Pharmacol. exp. Ther. 186, 630–639 (1973)
Watson, P.J.: Drug receptor sites in the isolated superior cervical ganglion of the rat. Europ. J. Pharmacol. 12, 183–193 (1970)
Weber, H.P., Petcher, T.J.: unpublished observations 1976
Weidmann, H.: Die Wirkung von D-Lysergsäure-diäthylamid und 5-Hydroxytryptamin auf spinale Reflexe. Helv. physiol. pharmacol. Acta 15, C43–C44 (1957)
Weidmann, H., Cerletti, A.: Die Wirkung von D-Lysergsäurediäthylamid und 5-Hydroxytryptamin (Serotonin) auf spinale Reflexe der Katze. Helv. physiol. pharmacol. Acta 15, 376–383 (1957)
Weidmann, H., Taeschler, M.: Influence des substances antimigraineuses sur les effets des catécholamines, de la sérotonine et de la stimulation des nerfs sympathiques. Extrait du Symposium International sur les Céphalées vasculaires, pp. 33–40. St-Germain-en-Laye 1966
Weiss, B.L., Aghajanian, G.K.: Activation of brain serotonin metabolism by heat: Role of midbrain raphe neurons. Brain Res. 26, 37–48 (1971)
Wellens, D., Szigetvari, E., Wauters, E.: Reflex vasodilation, ergotamine and uptake of circulating norepinephrine. Arch. int. Pharmacodyn. 183, 412–415 (1970)
Welsh, J.H.: Excitation of the heart of Venus mercenaria. Naunyn-Schmiedebergs Arch. Pharmacol. 219, 23–29 (1953)
Welsh, J.H.: Hydroxytryptamine: A neurohormone in the invertebrates. Fed. Proc. 13, 162–163 (1954a)
Welsh, J.H.: Marine invertebrate preparations useful in the bioassay of acetylcholine and 5-hydroxytryptamine. Nature (Lond.) 173, 955–956 (1954b)
Welsh, J.H.: Neurohormones. In: The Hormones. Pincus, G., Thimann, K.V. (eds.), Chap. 3. New York: Academic Press 1955
Welsh, J.H.: Neurohormones of invertebrates. 1. Cardioregulators of Cyprina and Buccinum. J. Marine Biol. Assoc. United Kingdom 35, 193–201 (1956)
Welsh, J.H.: Serotonin as a possible neurohumoral agent: Evidence obtained in lower animals. Ann. N.Y. Acad. Sci. 66, 618–630 (1957)
Welsh, J.H., McCoy, A.C.: Actions of d-lysergic acid diethylamide and its 2-bromo derivative on heart of Venus mercenaria. Science 125, 348 (1957I)
Wennmalm, Å.: Quantitative evaluation of release and reuptake of adrenergic transmitter in the rabbit heart. Acta physiol. scand. 82, 532–538 (1971a)
Wennmalm, Å.: Studies on mechanisms controlling the secretion of neurotransmitters in the rabbit heart. Acta physiol. scand. (Suppl.) 365, 1–36 (1971b)
Wenzel, D.G., Su, J.L.: Interactions of nicotine and tyramine with adrenergic blocking agents on ventricle strips. Arch. int. Pharmacodyn. 162, 180–185 (1966a)
Wenzel, D.G., Su, J.L.: Interactions between sympathomimetic amines and blocking agents on the rat ventricle strip. Arch. int. Pharmacodyn. 160, 379–389 (1966b)
West, G.B.: 5-Hydroxytryptamine, tissue mast cells and skin oedema. Int. Arch. Allergy 10, 257–275 (1957)
White, R.P., Denton, I.C., Robertson, J.T.: Differential effects of prostaglandins A1, E1 and F2α on cerebrovascular tone in dogs and rhesus monkeys. Fed. Proc. 30, 625 (1971a)
White, R.P., Heaton, J.A., Denton, I.C.: Pharmacological comparison of prostaglandin F2α, serotonin and norepinephrine on cerebrovascular tone of monkey. Europ. J. Pharmacol. 15, 300–309 (1971b)
Whitney, B.: A preliminary investigation of the pharmacology of longitudinal muscle strips from human isolated jejunum. J. Pharm. Pharmacol. 17, 465–473 (1965)
Wilhelmi, G.: Ueber die ulcerogene Wirkung von 5-Hydroxytryptamin am Rattenmagen und deren Beeinflussung durch verschiedene Pharmaka. Helv. physiol. pharmacol. Acta 15, C83–C84 (1957)
Wilhelmi, G., Schindler, W.: Über die gastrotrope Wirkung von 5-Hydroxytryptamin (HTA), seiner Vorstufen und der entsprechenden Isomeren bei der Ratte. Naunyn-Schmiedebergs Arch. Pharmacol. 236, 49–51 (1959)
Williams, L.T., Lefkowitz, R.J.: Alpha-adrenergic receptor identification by [3H]dihydroergocryptine binding. Science 192, 791–793 (1976)
Wiqvist, N.: Immediate and prolonged effects of relaxin on the spontaneous activity of the mouse and rat uterus. Acta endocr. (Kbh.) 32 (Suppl. 46), 3–32 (1959)
Wise, C.D., Ruelius, H.W.: The binding of serotonin in brain: A study in vitro of the influence of physicochemical factors and drugs. Biochem. Pharmacol. 17, 617–631 (1968)
Woodruff, G.N., Agar, J., Albani, M.J., Allen, K.A., Folkard, J.: Observations on some actions of ergometrine, noradrenaline and dopamine on the guinea-pig vas deferens and on the rabbit jejunum. J. Pharm. Pharmacol. 21, 860–861 (1969)
Woodruff, G.N., Walker, R.J.: The effect of dopamine and other compounds on the activity of neurones of Helix aspersa. Structure-activity relationships. Int. J. Neuropharmacol. 8, 279–289 (1969)
Woodruff, G.N., Walker, J.R., Kerkut, G.A.: Actions of ergometrine on catecholamine receptors in the guinea-pig vas deferens and in the snail brain. Comp. gen. Pharmacol. 1, 54–60 (1970)
Woodruff, G.N., Walker, R.J., Kerkut, G.A.: Antagonism by derivatives of lysergic acid of the effect of dopamine on Helix neurones. Europ. J. Pharmacol. 14, 77–80 (1971)
Woolley, D.W., Shaw, E.: Yohimbine and ergotoxin as naturally occurring antimetabolites of serotonin. Fed. Proc. 12, 293 (1953)
Woolley, D.W., Shaw, E.: A biochemical and pharmacological suggestion about certain mental disorders. Science 119, 587 (1954a)
Woolley, D.W., Shaw, E.: Some neurophysiological aspects of serotonin. Brit. med. J. 2, 122–126 (1954b)
Wright, A.M., Moorehead, M., Welsh, J.H.: Actions of derivatives of lysergic acid on the heart of Venus mercenaria. Brit. J. Pharmacol. 18, 440–450 (1962)
Wurzel, M.: Serotonin receptor in rabbit artery. Amer. J. Physiol. 211, 1424–1428 (1966)
Yamaguchi, T.: Effects of 5-hydroxytryptamine on isolated strips of the guinea-pig stomach. Brit. J. Pharmacol. 44, 100–108 (1972)
York, D.H.: Dopamine receptor blockade — a central action of chlorpromazine on striatal neurones. Brain Res. 37, 91–100 (1972)
Zakusov, V.V.: Principles of pharmacological influence on coronary chemoreflexes. Arch. int. Pharmacodyn. 140, 646–654 (1962)
Zarolinski, J.F., Browne, R.K.: Effects of dopamine on canine renal artery. Pharmacologist 13, 22 (1971)
Zatz, M., Roth, R.H.: Electroconvulsive shock raises prostaglandins F in rat cerebral cortex. Biochem. Pharmacol. 24, 2101–2103 (1975)
Zhabin, Y.M., Urazaeva, Z.V.: Influence of intravenous administration to pregnant rabbits of the diethylamide of lysergic acid on the content of serotonin, histamine and acetyl choline in mothers and young. Farmakol.i Toksikol. 38, 93–95 (1975)
Ziegler, M.G., Lovell, R.A., Freedman, D.X.: Effects of lysergic acid diethylamide on the uptake and retention of brain 5-hydroxytryptamine in vivo and in vitro. Biochem. Pharmacol. 22, 2183–2193 (1973)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1978 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Müller-Schweinitzer, E., Weidmann, H. (1978). Basic Pharmacological Properties. In: Berde, B., Schild, H.O. (eds) Ergot Alkaloids and Related Compounds. Handbook of Experimental Pharmacology / Handbuch der experimentellen Pharmakologie, vol 49. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66775-6_3
Download citation
DOI: https://doi.org/10.1007/978-3-642-66775-6_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-66777-0
Online ISBN: 978-3-642-66775-6
eBook Packages: Springer Book Archive